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ABSTRACT 
 
Organ transplantation (Tx) is a life-saving procedure for patients with end-stage organ 
failure. Survival rates have improved in recent decades, but the prevalence of 
neurological and psychiatric morbidities remain high. Pediatric heart, kidney, and liver 
Tx recipients generally perform in the low-average to average range in global 
intelligence. Comprehensive evaluations of other neuropsychological functions are 
rare. More studies of behavioral outcome – that is, health-related quality of life 
(HRQOL) and psychosocial adjustment (PSA) – have been published with outcomes 
generally lower than those reported in the general population and similar to those of 
children with other chronic diseases. Few studies have compared adjustment between 
children who have undergone different types of organ Tx. 
This is the first study to comprehensively assess cognitive and behavioral outcomes 
in a national sample of Finnish children who have undergone heart, kidney, or liver Tx. 
The thesis consists of four original studies that present data on 87 children who 
received transplants between 1993 and 2008. The first aim of this thesis was to assess 
both global intelligence and specific neuropsychological outcome in pediatric heart, 
kidney, and liver Tx recipients in the domains of attention, language, sensorimotor and 
visuospatial functions, memory and learning, and social processing. The second aim of 
this thesis was to compare HRQOL and PSA between the Tx groups. 
Within the cognitive outcome variables, a generalized effect on intelligence was 
observed, on a group level, in children who underwent heart or kidney Tx, particularly 
in children with neurological or neuroradiological abnormality. Liver Tx children had 
age-appropriate intelligence. All Tx groups tended to have more problems in nonverbal 
than in verbal intelligence. In neuropsychological functions, specific visuomotor and 
visuoconstructive impairment emerged in all Tx groups. In children without 
neurological comorbidity, few problems emerged in attention, language, or memory 
and learning. Parents reported difficulties in the same functions, as demonstrated 
through cognitive assessment, except for an increase in problems in memory and 
learning in the parental evaluations. Of the risk factors, early onset and longer disease 
duration prior to Tx were associated with poorer cognitive outcome, particularly in 
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nonverbal functions. Also, poorer graft function at the time of assessment was 
associated with lower verbal/auditory functions and memory in kidney Tx children. 
Within the behavioral outcome variables, no significant differences were observed 
in HRQOL or PSA between the Tx groups. Parents and teachers reported an increase in 
internalizing and in the total number of psychiatric symptoms, but these were 
attributable mainly to a significant increase in somatic complaints. Younger Tx 
children reported lower HRQOL than did adolescent patients. However, both age 
groups found that their health made it more difficult to be with friends, for example, 
and attend school or hobbies. Of the risk factors, shorter follow-up time after Tx was 
associated with poorer behavioral outcome. Neurological comorbidity was associated 
with both self-reported HRQOL and proxy-reported PSA, yet family structure (child 
not living with both biological parents) and poorer parental HRQOL were also 
negatively associated with the child’s PSA. 
The outcomes of the majority of school-aged children who have undergone a solid 
organ Tx are reassuring. However, a significant minority exhibit considerable global 
cognitive delay. Additionally, the cognitive profile suggests that Tx children may be 
susceptible to negative effects in the posterior cortex with associated visuospatial 
difficulties. Thus, follow-up evaluations of children who have undergone Tx need to 
include assessment of both intelligence and of other neuropsychological functions, 
particularly in the domains of visuomotor, visuoconstructive, and visuospatial 
functions. Further, Tx children and their families should be offered psychosocial 
support. During cognitive and socioemotional development, new issues may arise; 
consequently, counseling as a routine part of treatment throughout childhood and 
adolescence is essential. 
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TIIVISTELMÄ 
 
Moderni lääketiede pystyy elinsiirtoleikkausten avulla pelastamaan kasvavan määrän 
lapsia, joiden elämä on ollut uhattuna. Eloonjäämisluvut ovat parantuneet viime 
vuosikymmenten aikana, mutta neurologisten ja psykiatristen ongelmien esiintyvyys on 
pysynyt korkeana. Sydän-, munuais- tai maksansiirron saaneiden lasten suoriutuminen 
älykkyystesteissä sijoittuu ryhmätasolla alhaisen keskitason ja keskitason välille. 
Kattavia tutkimuksia muista neuropsykologisista toiminnoista on vähän. 
Behavioraalisia muuttujia eli terveyteen liittyvää elämänlaatua ja psykososiaalista 
sopeutumista on tutkittu laajemmin. Tulokset ovat yleisesti huonompia verrattuna 
väestön keskiarvoon, mutta samanlaisia kuin muilla pitkäaikaissairailla lapsilla. Harvat 
tutkimukset ovat verranneet sopeutumista eri siirtoryhmien välillä. 
Tämä on ensimmäinen kattava tutkimus kognitiivisista ja behavioraalisista 
muuttujista kansallisessa otoksessa sydän-, munuais- tai maksansiirron saaneista 
suomalaislapsista. Väitöskirja koostuu neljästä alkuperäisestä tutkimuksesta, jotka 
esittelevät vuosina 1993-2008 elinsiirron saaneiden 87 lapsen tuloksia. Väitöskirjan 
ensimmäinen päätarkoitus oli tutkia sydän-, munuais- tai maksansiirron saaneiden 
lasten yleistä älykkyyttä sekä tarkemmin neuropsykologisia toimintoja seuraavilla 
alueilla: tarkkaavuus, kielelliset toiminnot, sensomotoriset ja visuospatiaaliset 
toiminnot, muisti ja oppiminen sekä sosiaalinen havaitseminen. Väitöskirjan toinen 
päätarkoitus oli verrata terveyteen liittyvää elämänlaatua ja psykososiaalista 
sopeutumista siirtoryhmien välillä. 
Kognitiivisissa muuttujissa laaja-alainen vaikutus älylliseen suorituskykyyn oli 
huomattavissa ryhmätasolla sydän- ja munuaissiirron saaneilla lapsilla. Tämä koski 
erityisesti lapsia, joilla oli todettu neurologisia tai neuroradiologisia poikkeavuuksia. 
Maksansiirron saaneilla lapsilla älyllinen suorituskyky oli ikätasoista. Kaikissa 
siirtoryhmissä havaittiin enemmän vaikeuksia ei-kielellisessä kuin kielellisessä 
älykkyydessä. Neuropsykologisissa toiminnoissa vaikeuksia ilmeni visuomotorisissa ja 
visuokonstruktiivisissa toiminnoissa kaikissa siirtoryhmissä. Lapsilla, joilla ei ollut 
neurologisia poikkeavuuksia ei yleisesti ollut ongelmia tarkkaavuudessa, kielellisissä 
toiminnoissa tai muistissa ja oppimisessa. Vanhemmat raportoivat ongelmia samoilla 
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toiminnan alueilla kuin mitä ilmeni kognitiivisessa tutkimuksessakin. Lisäksi 
vanhemmat raportoivat enemmän ongelmia muistin ja oppimisen alueilla. 
Riskitekijöistä varhainen sairastuminen ja pidempi sairausaika ennen siirtoa olivat 
yhteydessä huonompiin kognitiivisiin tuloksiin, erityisesti ei-kielellisissä toiminnoissa. 
Lisäksi heikompi siirteen toiminta tutkimuksen ajankohtana oli yhteydessä huonompiin 
kielellisiin/auditiivisiin toimintoihin ja muistiin munuaissiirron saaneilla lapsilla. 
Behavioraalisissa muuttujissa terveyteen liittyvä elämänlaatu ja psykososiaalinen 
sopeutuminen eivät eronneet siirtoryhmien välillä. Vanhemmat ja opettajat raportoivat 
enemmän sisäänpäin suuntautuneita ongelmia ja psykiatristen oireiden 
kokonaisesiintyvyyttä, mikä johtui pääasiassa somaattisten oireiden kohonneesta 
määrästä. Nuoremmat potilaat arvioivat terveyteen liittyvän elämänlaatunsa 
huonommaksi kuin murrosikäiset potilaat. Kummatkin ikäryhmät raportoivat 
terveytensä vaikuttavan mm. ystävien kanssa vietettyyn aikaan ja koulunkäyntiin tai 
harrastuksiin. Riskitekijöistä pidempi seuranta-aika siirrosta oli tärkeä lieventävä tekijä 
behavioraalisissa muuttujissa. Neurologinen komorbiditeetti oli yhteydessä sekä lasten 
omaan arvioon elämänlaadustaan että vanhempien ja opettajien arvioon lasten 
sopeutumisvaikeuksista. Myös perherakenne (lapsi ei asunut kummankin biologisen 
vanhempansa kanssa) ja vanhempien oma heikentynyt terveyteen liittyvä elämänlaatu 
olivat yhteydessä lasten huonompaan sopeutumiseen. 
Enemmistöllä kouluikäisistä elinsiirtolapsista toimintataso on hyvä. Merkittävällä 
vähemmistöllä on kuitenkin huomattavan laaja-alaisia kognitiivisen kehityksen 
ongelmia. Tämän lisäksi siirron saaneiden lasten kognitiivinen profiili viittaa vaurioihin 
aivokuoren taemmissa osissa ja näihin liittyviin visuospatiaalisiin ongelmiin. 
Siirtolasten seurannassa tulisi näin ollen yleisen älykkyyden lisäksi tutkia muita neuro-
psykologisia toimintoja huomioiden erityisesti visuomotoriset, visuokonstruktiiviset ja 
avaruudellisen hahmottamisen ongelmat. Siirtolapsille ja heidän perheilleen tulisi 
lisäksi tarjota psykososiaalista tukea. Tavanomaisen kognitiivisen ja 
sosioemotionaalisen kehityksen myötä saattaa ilmetä uudenlaisia kysymyksiä ja 
psyykkisen tuen tulisikin olla olennainen osa lasten saamaa hoitoa läpi lapsuuden ja 
nuoruuden. 
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SAMMANFATTNING 
 
Organtransplantation är en livräddande behandling för patienter med organsvikt. Under 
de senaste årtionden har chanserna för överlevnad kontinuerligt förbättrats. Trots detta 
förblir förekomsten av neurologisk och psykiatrisk komorbiditet hög. Barn som 
genomgått en hjärt-, njur- eller levertransplantation uppvisar generellt en intelligens 
som ligger mellan låg normalzon och normalzon. Det finns få omfattande utredningar 
av andra neuropsykologiska funktioner. Ett flertal studier har behandlat 
beteendemässiga variabler som hälsorelaterad livskvalitet och psykosocial anpassning. 
Resultaten är generellt under populationsmedelvärden och likartade som för barn med 
andra kroniska sjukdomar. Enbart ett fåtal studier har jämfört anpassning mellan olika 
pediatriska transplantationsgrupper. 
Detta är den första omfattande utredningen av kognitiva och behaviorala variabler i 
ett nationellt urval av finska barn som genomgått en hjärt-, njur- eller 
levertransplantation. Avhandling består av fyra delstudier som presenterar data på 87 
barn som genomgått organtransplantation mellan 1993 och 2008. Avhandlingens första 
syfte var att utvärdera både intelligens och specifika neuropsykologiska funktioner hos 
barn som genomgått en hjärt-, njur- eller levertransplantation inom följande områden: 
uppmärksamhet, språk, sensomotoriska och visuospatiala funktioner, minne och 
inlärning samt social perception. Avhandlingens andra syfte var att jämföra 
hälsorelaterad livskvalitet och psykosocial anpassning mellan transplantations-
grupperna. 
Hos barn som genomgått en hjärt- eller njurtransplantation observerades på 
gruppnivå en påverkan på intelligens, speciellt hos barn med neurologisk eller 
neuroradiologisk avvikelse. Barn som genomgått en levertransplantation hade däremot 
åldersenlig intelligens. Alla grupper tenderade ha mera problem inom nonverbal än 
verbal intelligens. Barn som genomgått en organtransplantation hade därtill specifika 
visuomotoriska och visuokonstruktiva svårigheter. Hos gruppen barn utan neurologisk 
avvikelse framkom få problem med uppmärksamhet, språk eller minne och inlärning. 
Föräldrarnas rapportering av funktionsnedsättningar överensstämde med resultaten från 
den kognitiva utredningen. Föräldrarna rapporterade därtill problem med minne och 
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inlärning. Tidig sjukdomsdebut och en längre sjukdomstid före transplantationen var 
associerade med sämre kognitiva resultat, speciellt i nonverbala funktioner. Det visade 
sig också att en sämre organfunktion vid tidpunkten för studien var associerad med 
sämre verbal/auditiv funktion och minne hos njurtransplanterade barn. 
Mellan transplantationsgrupperna observerades inga skillnader i hälsorelaterad 
livskvalitet eller psykosocial anpassning. Föräldrar och lärare rapporterade förhöjda 
inåtvända (internaliserade) och totala antal psykiska problem, men dessa berodde 
främst på en signifikant ökning i antalet somatiska symptom. Yngre barn rapporterade 
lägre hälsorelaterad livskvalitet än tonåringar. Båda åldersgrupperna upplevde att deras 
hälsotillstånd försvårade bl.a. förmågan att umgås med vänner och att delta i skolgång 
eller hobbyn. Kortare uppföljningstid efter transplantationen var associerad med mera 
beteendemässiga problem. Neurologisk komorbiditet påverkade både barnens egen 
utvärdering av sin livskvalitet samt föräldrarnas och lärarnas rapportering av 
psykosociala anpassningssvårigheter. Även familjestruktur (barnet bodde inte med sina 
båda biologiska föräldrar) och sämre hälsorelaterad livskvalitet hos föräldrarna var 
associerade med sämre anpassning hos barnet. 
Majoriteten av barn i skolåldern som genomgått en organtransplantation har en bra 
funktionsnivå. En betydande minoritet uppvisar ändå omfattande problem i den 
kognitiva utvecklingen. Dessutom tyder den kognitiva profilen på en benägenhet för 
negativa effekter i hjärnbarkens posteriora delar, vilket är förknippat med visuospatiala 
svårigheter. I uppföljningen är det därför nödvändigt att utvärdera både allmän 
intelligens såväl som specifika neuropsykologiska funktioner, med särskild tonvikt på 
de visuomotoriska, visuokonstruktiva och visuospatiala funktionerna. Familjer med 
barn som genomgått en organtransplantation borde även erbjudas psykosocialt stöd. 
Detta stöd borde erbjudas som en väsentlig del av vården under hela uppväxten 
eftersom nya frågor kan uppstå under barnets kognitiva och socioemotionella 
utveckling. 
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1 INTRODUCTION 
 
The first attempts at pediatric organ transplantation (Tx) took place in the 1950s and 
1960s. Since then, medical advances have dramatically increased survival rates and 
improved long-term outcome. At the turn of the millennium, the first survivors of 
pediatric solid organ Tx successfully entered adulthood (Groothoff, 2005). Since 
survival rates have improved, the research focus is switching from merely medical 
aspects to cognitive and behavioral outcome. However, few comprehensive 
neuropsychological evaluations in this patient population have been published. Health-
related quality of life (HRQOL) and psychosocial adjustment (PSA) have been studied 
more extensively, but few studies have compared adjustment in children who have 
undergone different types of organ Tx. 
The most commonly transplanted organs are the kidney, liver, and heart. In Finland, 
the first pediatric kidney, liver, and heart Tx took place in 1986, 1987, and 1991, 
respectively. Currently, patient five-year survival rates are 97%, 77%, and 83%, for 
kidney, liver and heart Tx (Transplantation Registry Report: Children's Hospital, 2006). 
These rates are comparable to those from centers around the world (Kirk et al., 2011; 
Smith, Stablein, Munoz, Hebert, & McDonald, 2007; Soltys et al., 2007). 
Children who have undergone organ Tx are a heterogeneous patient group. The 
majority of these children have a congenital disease which may have compromised 
their early development, even prenatally. A minority experiences a healthy infancy with 
sudden disease onset in later childhood. Studies on the cognitive and behavioral 
outcome in the first Tx patients treated – particularly kidney Tx children – have been 
undertaken at the Childrens’s Hospital in Helsinki (Apajasalo, Rautonen, Sintonen, & 
Holmberg, 1997; Qvist et al., 2002; Qvist et al., 2004; Valanne, Qvist, Jalanko, 
Holmberg, & Pihko, 2004). This thesis focuses on the cognitive and behavioral 
outcome in a recent cohort of Finnish heart, kidney, and liver Tx patients. 
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1.1 End-stage organ failure and transplantation in childhood 
 
End-stage organ failure places a child at risk for malnutrition, growth failure, 
infections, and cardiovascular insult, all of which are a risk for development. A longer 
waiting time for Tx prolongs the time spent in organ failure, with its deleterious effects. 
The patients undergo painful medical and surgical procedures affecting both their 
emotional and physical development. In addition, all patients experience 
hospitalizations which interrupt family life, day care or school, and normal social 
interaction. Moreover, other medical risk factors, such as prematurity and the presence 
of genetic syndromes, are overrepresented in this patient population, which may affect 
neurological outcome. 
Other risks are also associated with the Tx operation itself, especially in heart and 
liver Tx. In liver Tx, the vena cava is cross-clamped for 30-60 minutes, leading to 
decreased cardiac output and altered hemodynamics (Fine, Webber, Harmon, Kelly, & 
Olthoff, 2007; Harjula & Höckerstedt, 1995). Heart Tx involves cardiopulmonary 
bypass and circulatory arrest. As discussed by Sarajuuri and colleagues, both methods 
are associated with cerebral autoregulation disturbance, microembolic injury, and a 
systemic inflammatory response (Sarajuuri et al., 2007), and, thus, with possible 
neurodevelopmental consequences (Bellinger et al., 2003; Sarajuuri et al., 2007). 
After organ Tx, the receiver’s immune system responds to the donor antigens. 
Lifelong immunosuppressive medication is necessary to avoid graft rejection. Patients 
receive higher doses in the early post-operative period, followed by low doses of 
different immunosuppressive drugs in combination to obtain the best therapeutic 
outcome with the fewest side-effects (Fine et al., 2007; Webber, McCurry, & Zeevi, 
2006). Side-effects to medication include mild medical symptoms such as susceptibility 
to infections, headache, and hypertension, as well as severe symptoms such as kidney 
dysfunction and malignancies (Schonder, Mazariegos , & Weber, 2010; Uutela, Qvist, 
Holmberg, Pihko, & Jalanko, 2009). Cosmetic side-effects, such as hirsutism, gingival 
hyperplasia, acne, and skin infections, are also common (Schonder et al., 2010). Some 
side-effects, such as tremor, are commonly considered reversible; more symptoms 
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appear with higher doses of medication administered early post-operatively (Harjula & 
Höckerstedt, 1995). 
Neurological complications are also common, particularly during the first months 
post-Tx, and have been reported in up to 35% of pediatric liver Tx recipients (Erol, 
Alehan, Ozcay, Canan, & Haberal, 2007). The most common neurological 
complications are seizures, encephalopathy, posterior reversible encephalopathy 
syndrome, central nervous system infection, and cerebrovascular accidents (Fernandez 
et al., 2010; LaRosa, Jorge Baluarte, & Meyers, 2011). Neurological complications are 
often associated with the introduction of immunosuppressive medication and may be 
reversed by reducing medication (Erol et al., 2007). The etiology of neurotoxicity is 
poorly understood and may occur even though the dosage falls in the therapeutic range 
(Bartynski et al., 2001). 
 
1.1.1 Heart failure 
 
The most common indications for heart Tx in childhood are congenital heart disease 
(CHD) and cardiomyopathy (Kirk et al., 2011). CHD develops early in fetal 
development and results in structural defects of the heart or the vessels carrying blood 
to and from the heart. These diagnoses include hypoplastic left heart syndrome, 
Tetralogy of Fallot, transposition of the great arteries, and pulmonary atresia. 
Newborns with CHD are at risk for hypoxemia (low blood oxygen), hypotension (low 
blood pressure), and diminished cerebral blood flow (Licht et al., 2004). Hypoxemia 
has been associated with cognitive and behavioral effects (Bass et al., 2004) and low 
cerebral blood flow with an increased incidence of periventricular leukomalacia in 
children with CHD (Licht et al., 2004). Most cases of severe heart disease are 
diagnosed within the first few months of life. These children regularly undergo one or 
more corrective heart surgeries, which expose them to cardiopulmonary bypass, and 
possibly to circulatory arrest. In some cases, a mechanical ventricular assist device is 
implanted to bridge the time to Tx (Jahnukainen et al., 2013). 
Cardiomyopathy usually presents later and with acute onset. It affects the heart 
muscle, leading to heart failure. Its etiology is often unknown, but more and more 
17 
 
genetic diseases are detected (Bhati, Sheridan, Mill, & Selzman, 2005). Some of these 
may be part of a syndrome that also includes neurological symptoms. However, 
cardiomyopathy has generally not been associated with adverse brain outcomes. In our 
patient sample, children who had undergone heart Tx were on average slightly older at 
the time of Tx compared to the other Tx groups. 
 
1.1.2 Kidney failure 
 
The most common indications for kidney Tx in children worldwide are congenital 
malformations leading to obstruction of urinary flow (urethral valve), different stages 
of kidney malformations (dysplasia), and inflammations of small kidney vessels 
(glomerulonephritis). In Finland, however, the most common disease leading to 
pediatric Tx is congenital nephrosis of the Finnish type (CNF). The basic characteristic 
of CNF is the fulminant loss of protein through the kidneys, which occurs already in 
utero (Jalanko, 2009). At the Childrens’s Hospital in Helsinki, children with CNF 
undergo bilateral nephrectomy when they attain the critical weight of 7 kg, after which 
they receive night time peritoneal dialysis in the home. Kidney Tx is performed when 
the child weighs over 9 kg, usually between the ages of one and two. In the youngest 
patients, the procedure is complicated by the difference in size between the adult-size 
kidney and the small patient, which may increase the risk of thrombosis and ureteral 
complications (Jalanko, 2009). 
In end-stage kidney disease, or uremia, waste products that are normally filtered by 
the kidneys to form urine remain in the blood. This may lead to uremic encephalopathy, 
characterized by an altered mental status and, if left untreated, coma and death 
(Stewart, Kennard, Waller, & Fixler, 1994). Additionally, in end-stage kidney disease, 
the kidneys’ ability to regulate blood pressure and the body balance of many hormones 
is disturbed (Jalanko, 2009). Although dialysis is readily initiated, dialysis treatment 
also carries the risks for hypo- and hypertension, seizures, and encephalopathy. The 
control of blood volume and blood pressure is particularly difficult in the youngest 
patients (Laakkonen, 2011). 
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1.1.3 Liver failure 
 
The most common indications for liver Tx in children are structural defects, especially 
biliary atresia (i.e., the absence or under-development of biliary tracts), congenital 
metabolic diseases (e.g., Wilson’s disease, hyperoxaluria), hepatic malignancy, or 
infectious cause (hepatitis) (Fine et al., 2007; Harjula & Höckerstedt, 1995). The single 
most common disease leading to pediatric liver Tx worldwide is biliary atresia. 
Correction of biliary atresia requires early surgical correction to provide biliary 
drainage. Despite this measure, most children develop liver cirrhosis and liver failure 
(Fine et al., 2007). 
In end-stage liver disease, the liver’s ability to degrade cerebrotoxic substances in 
the blood, such as ammonia, fails. The accumulation of these toxic substances may lead 
to hepatic encephalopathy (Stewart et al., 1994), which resembles uremic 
encephalopathy. Also, malnutrition remains a problem despite nutritional support (van 
Mourik et al., 2000). Early Tx is often the only option to avoid permanent brain 
damage. 
 
1.2 Cognitive outcome after transplantation and its risk factors 
 
In school-aged children with an organ Tx, studies have reported intelligence in the low-
average to average range compared to test norms (Adebäck, Nemeth, & Fischler, 2003; 
Falger et al., 2008; Kaller et al., 2005; Krull, Fuchs, Yurk, Boone, & Alonso, 2003; 
Qvist et al., 2002; Yssaad-Fesselier et al., 2009). Studies using a matched control group 
have found significantly lower intelligence than in healthy children (Brouhard et al., 
2000; Wray & Radley-Smith, 2005). Most studies in the field of pediatric Tx have 
assessed only global intelligence. Some studies have assessed one or a few other 
neuropsychological functions, but comprehensive evaluations in the same patients are 
rare. The results have been somewhat varied and are presented below, with a focus on 
school-aged children and the most recent findings. 
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1.2.1 Heart transplantation 
 
A majority of studies on heart Tx children come from two research groups. The 
research findings from Harefield Hospital (U.K.) consistently report outcome in 
developmental and intelligence tests within average range among patients with heart or 
heart-lung Tx according to test norms, but lower when compared to a healthy control 
group (Wray, Pot-Mees, Zeitlin, Radley-Smith, & Yacoub, 1994; Wray, Long, Radley-
Smith, & Yacoub, 2001; Wray & Radley-Smith, 2005; Wray & Radley-Smith, 2006). 
However, researchers have suggested that the test norms of the British Ability Scales 
are outdated with healthy children achieving scores higher than average; thus, the 
statement that the Tx groups perform within average may be too optimistic (Wray et 
al., 2001). In the areas covered by the British Ability Scales, specific impairments 
emerged at school-age in short-term memory, nonverbal reasoning, and speed of 
information processing, compared to a control group (Wray et al., 1994). 
Research findings from Loma Linda University Children’s Hospital (U.S.A.) 
demonstrate average mental development and mildly delayed motor development in 
infants with Tx, when compared to test norms (Freier et al., 2004). In older children 
and adolescents, intelligence, expressive and receptive language, and visuomotor 
integration were in the borderline range (Baum et al., 2004; Krishnamurthy, Freier 
Randall, & Chinnock, 2011). The Loma Linda studies focus on children transplanted 
before the age of one year. Because of stringent exclusion criteria, nearly half of the 
sample was excluded, meaning that the results presented may represent a best-case 
scenario of infant heart Tx (Baum et al., 2004). Nearly identical results have been 
reported in a multicenter study that included the Loma Linda Hospital (Mahle et al., 
2006). Similarly, other studies of school-aged children report specific 
neuropsychological impairments in expressive and receptive language (Fleisher et al., 
2002) and in visuomotor and fine motor functions (Uzark, Spicer, & Beebe, 2009). 
Studies on the longitudinal effect of heart Tx in school-aged children have found no 
changes over time when assessing cognitive and academic skills one, two (Wray et al., 
2001; Wray & Radley-Smith, 2005), or three years post-Tx (Wray et al., 2001), thus 
indicating stability over time. For a small group of younger children (aged ≤ 3.5 years), 
however, a significant decrease was observed in hand-eye coordination and in the 
20 
 
overall developmental quotient in the first years after Tx (Freier et al., 2004; Wray & 
Radley-Smith, 2005) and among school-aged children in arithmetic between one and 
three years post-Tx (Wray & Radley-Smith, 2006). Risk factors for poorer cognitive 
outcome include longer waiting time for Tx (Ikle, Hale, Fashaw, Boucek, & Rosenberg, 
2003), cardiopulmonary bypass time (Baum et al., 2004), number of serious infections 
and surgical procedures post-Tx (Baum et al., 2004), and prolonged hospitalization 
(Baum et al., 2004; Mahle et al., 2006). However, other studies have found no 
associations between the aforementioned variables and cognitive outcome (Baum et al., 
1993; Brosig, Hintermeyer, Zlotocha, Behrens, & Mao, 2006). Overall, one factor 
places the children at risk for later cognitive deficits, and that factor is decreased 
oxygenation, due to both chronic heart disease and repair surgeries (Todaro, Fennell, 
Sears, Rodrigue, & Roche, 2000). 
 
1.2.2 Kidney transplantation 
 
Three studies have compared the performance of kidney Tx children to a matched 
control group. In an early study, Fennel and colleagues (1984) found greater 
improvement in performance intelligence (PIQ) and math in the kidney Tx group than 
in the healthy control group in assessments undertaken before the initiation of dialysis 
and one month post-kidney Tx; the kidney Tx children reached at that point the level of 
the control group. In verbal intelligence (VIQ), however, both groups had similar 
scores at each assessment. Additionally, no differences were found between groups at 
one year post-kidney Tx in measures of intelligence, achievement, problem solving, 
verbal memory, or attention. However, the groups were matched for intelligence, which 
explains their similar cognitive level (Fennell, Rasbury, Fennell, & Morris, 1984). 
Later, a multicenter study found significantly poorer performance on measures of 
nonverbal intelligence and achievement (spelling, reading, and arithmetic) in kidney Tx 
children than in their siblings (Brouhard et al., 2000). Another study found significant 
improvement in developmental/intelligence level, from borderline to low-average 
range, in a one-year follow-up of children with chronic kidney disease who received 
kidney Tx compared to children with chronic kidney disease who did not receive Tx 
(Icard, Hooper, Gipson, & Ferris, 2010). 
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Two later studies compared cognitive functions in kidney Tx children to normative 
data from test norms. Falger and colleagues (2008) found impairment in PIQ and motor 
performance (Falger et al., 2008). A study of the first kidney Tx children at the 
Childrens’s Hospital in Helsinki reported intelligence in the low-average range. Group-
level performance in neuropsychological assessment was within average in attention 
and executive functions, language, visuospatial processing, and memory and learning; 
however, 24%, 6%, 24%, and 20% of the patients, respectively, performed at or below 
the borderline level (Qvist et al., 2002). 
Early studies associated poorer cognitive outcome with the risk factors of early onset 
of kidney disease (Fennell et al., 1984; Lawry, Brouhard, & Cunningham, 1994) and 
longer disease duration prior to Tx (Fennell et al., 1984). In more recent studies, 
however, cognitive impairment has been associated with neurological comorbidity 
(Falger et al., 2008), hypertensive crises and seizures during dialysis (Qvist et al., 
2002), and lower socioeconomic status (Falger et al., 2008). Thus, early Tx may 
alleviate the effects of early onset of kidney disease, yet longer disease duration prior to 
Tx and hemodynamic changes remain risk factors for cognitive impairment. 
 
1.2.3 Liver transplantation 
 
In a large multicenter study, five- to seven-year-old liver Tx recipients had a group 
mean of average intelligence, but as many as 26% performed in the borderline range, 
and 4%, significantly below average (Sorensen et al., 2011). Compared to normative 
data, specific neuropsychological impairments in school-aged patients have been 
reported in expressive and receptive language (Krull et al., 2003), visuospatial 
performance (Stewart et al., 1991; Yssaad-Fesselier et al., 2009), sequential processing 
of information (Schulz, Wein, Boeck, Rogiers, & Burdelski, 2003), working memory 
(Kaller, Langguth, Ganschow, Nashan, & Schulz, 2010; Yssaad-Fesselier et al., 2009), 
and sustained attention (Kaller, Langguth et al., 2010). 
The most comprehensive neuropsychological assessments to date, and the only ones 
who used a control group, have compared the performance of liver Tx recipients to that 
of another patient group with early onset of a disease thought not to affect cognitive 
development, namely, cystic fibrosis (Krull et al., 2003; Stewart et al., 1991). The 
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results are contradictory. The earlier study by Stewart and colleagues (Stewart et al., 
1991) found predominantly nonverbal deficits, and the more recent one, by Krull and 
colleagues (Krull et al., 2003), language deficits. The study by Krull and colleagues 
included a patient sample with more severe disease, who received a transplant at a 
younger age. 
In the light of studies over the past 15 years, poorer cognitive outcome may be 
associated mainly with the pre-Tx risk factors of longer disease duration (Kaller et al., 
2005; Kaller, Langguth et al., 2010; Schulz et al., 2003), poorer physical development, 
and malnutrition (Gilmour, Adkins, Liddell, Jhangri, & Robertson, 2009; Kaller et al., 
2005; Schulz et al., 2003; Wayman, Cox, & Esquivel, 1997), as well as health status 
post-Tx (Krull et al., 2003; Wayman et al., 1997). Most studies have found no 
relationship between follow-up time since liver Tx and cognitive outcome for follow-
up times of one to ten years (Adebäck et al., 2003; Kaller et al., 2005; Kaller et al., 
2010; Krull et al., 2003). However, cognitive performance may deteriorate shortly after 
Tx to improve in the long term to its pre-Tx level (van Mourik et al., 2000; Wayman et 
al., 1997). Thus, in liver Tx children, longer disease duration before Tx, with its 
deleterious effect on nutritional status and growth, remains a significant risk factor for 
cognitive development. 
 
To summarize, the literature on cognitive outcome after pediatric organ Tx is 
growing, yet these studies have some inherent limitations. With regard to assessment 
methods, most studies assessed global intelligence only, and less is known about 
specific neuropsychological effects. Evaluation methods developed for toddlers have 
seen frequent use, yet these methods rely heavily on motor skills, and their predictive 
value is not great (Hack et al., 2005; Wray & Radley-Smith, 2006). The use of 
assessment methods for toddlers and older children, as well as different versions of the 
same tests within the same study further limit generalizability. Test results have 
generally been compared to test norms with only a few studies that included a control 
group. 
With regard to patient samples, several successive studies have investigated the 
same children, which may lead to a more homogeneous picture of the population than 
is actually true. Only a few studies report results from the whole patient population. 
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Many studies have used exclusion criteria such as cognitive delay (Kaller et al., 2005; 
Kaller et al., 2010; Mendley & Zelko, 1999), prematurity (Stewart et al., 1991; 
Wayman et al., 1997), seizures (Fennell et al., 1990), changes evident on brain-
magnetic resonance imaging (Kennard et al., 1999; Stewart et al., 1991), and other 
neurological or psychiatric conditions/sequelae (Baum et al., 2004; Brouhard et al., 
2000; Krull et al., 2003; Wray et al., 1994). Differences in inclusion criteria, sample 
size, diagnostic groups, ages at onset of disease and at Tx, follow-up times, and 
assessment methods may well have affected the results between studies. Early patient 
cohorts also differ from more recent ones. Owing to advances in medical care, patients 
today have more promising outcomes than did early patient cohorts, yet more 
demanding patients are accepted for Tx, leading to a possible increase in neurological 
comorbidity. The varying use of neurodevelopmental delay as a listing criterion may 
further influence outcomes between centers (Richards, Crawley, & Magnus, 2009). 
Evaluation of the cognitive profile of Tx children requires a comprehensive 
assessment of intelligence and specific neuropsychological functions in the same 
patient sample without excluding patients with neurological comorbidity or risk factors. 
A measure designed for a wide age-range enables the assessment of all children with 
the same measure. Including a control group is also important. Using another patient 
group as a control group facilitates the distinction between disease-specific cognitive 
deficits and those caused by childhood chronic disease per se. At school entry, 
however, children are compared to peers of the same age. Consequently, the use of a 
healthy age-matched control group sheds light on cognitive functioning in relation to 
age-expectations. 
 
1.3 Behavioral outcome after organ transplantation 
 
For a child with end-stage organ failure, Tx significantly improves wellbeing (LaRosa 
et al., 2011; Taylor, Franck, Gibson, & Dhawan, 2005). Even so, the level of HRQOL 
and PSA after Tx has been lower than that reported in the general population and 
similar to that of children with other chronic diseases (Alonso et al., 2010; Limbers et 
al., 2011; Shemesh et al., 2005). The concept of HRQOL comprises those aspects of 
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physical, mental, and social wellbeing that are affected by health. PSA comprises 
behavioral, emotional, and social functioning. 
Comparisons of different pediatric solid organ Tx groups have been suggested (Fine 
et al., 2004), but few studies exist. Similar HRQOL and PSA have been reported in 
kidney and liver Tx recipients (Limbers et al., 2011; Wu, Aylward, Steele, Maikranz, & 
Dreyer, 2008). However, more at-risk scores in PSA emerged in self-reports of liver Tx 
than in those of kidney Tx recipients (Wu et al., 2008). Two research groups have 
recently reported studies comparing adolescents with a heart, kidney, and liver Tx. In 
the first study of post-traumatic stress symptoms in Tx patients and their parents, the 
authors hypothesized that the type of transplant with its associated prognosis and risk of 
mortality would predict symptoms in both patients and their parents, with the fewest 
symptoms after kidney and the most after heart Tx. Yet, they detected no group 
differences (Mintzer et al., 2005; Young et al., 2003). The second study with both 
cross-sectional and prospective data found no group differences in HRQOL (Devine, 
Reed-Knight, Simons, Mee, & Blount, 2010; Devine et al., 2011; Simons et al., 2008). 
In their prospective study, however, self-reports of heart Tx recipients revealed better 
mental health than did those of liver Tx recipients at the 18-month follow-up, but the 
difference did not remain after controlling for baseline mental health (Devine et al., 
2011). However, results differed depending on whether they were obtained from the 
children or their caregivers (Devine et al., 2010; Simons et al., 2008; Wu et al., 2008), 
which represents a general finding (Achenbach, Dumenci, & Rescorla, 2002; Eiser & 
Morse, 2001). At the Childrens’s Hospital in Helsinki, a comparison study between the 
first children receiving a heart, kidney, or liver Tx revealed no differences in HRQOL 
utility scores between Tx groups, except for greater discomfort in kidney Tx 
preadolescents and the lowest level of satisfaction with appearances in liver Tx 
adolescents. Further, a discrepancy was found between age groups; preadolescents 
reported lower HRQOL than did adolescent patients (Apajasalo et al., 1997). 
Comparison studies between heart, kidney, and liver Tx children have not included a 
comprehensive evaluation of childhood psychopathologies assessed with a PSA 
questionnaire. Similarly, teacher-reports are rare. Since reports indicate problems in 
social and school function (Alonso et al., 2010; Qvist et al., 2004; Wray & Radley-
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Smith, 2007), knowing teachers’ views on how Tx children function behaviorally and 
socially in the class room is important. 
 
1.3.1 Risk factors for behavioral outcome 
 
Risk factors associated with post-Tx HRQOL and PSA in children are numerous and 
vary between studies depending in large part on different assessment methods, various 
inclusion criteria, different age groups, and the risk factors under study. Medical risk 
factors (i.e., neurological comorbidity, medication side-effects, secondary disease, 
adherence, or rejection episodes), personal factors (i.e., psychiatric history, low self-
esteem, or emotional state), and family-related factors (i.e., family conflict, parental 
income, mother’s distress, or parental physical functioning) have been associated with 
behavioral outcome (Devine et al., 2011; Qvist et al., 2004; Simons et al., 2008; Taylor, 
Franck, Gibson, Donaldson, & Dhawan, 2009; Wray & Radley-Smith, 2007). Some 
reports have found that psychological (i.e., family functioning, mother’s distress, or 
pre-Tx PSA) rather than medical risk factors are important for psychological 
functioning after pediatric Tx (DeMaso, Douglas Kelley, Bastardi, O'Brien, & Blume, 
2004; Wray & Radley-Smith, 2007). 
Factors known to predict psychological difficulties among Finnish children in the 
general population include a history of psychopathology, parental education, family 
structure, family functioning, and parental wellbeing (Almqvist et al., 1999; Sourander 
et al., 2006). Psychiatric history, family functioning, and parental wellbeing have also 
been associated with outcome after Tx (DeMaso et al., 2004; Taylor et al., 2009; Wray 
& Radley-Smith, 2007), while results on parental income have been inconclusive 
(Devine et al., 2011). Marital status (married vs. not married) has shown no association 
with outcome after Tx (Devine et al., 2010; Simons et al., 2008); family structure 
(living with both biological parents), however, has a greater impact on a child’s 
everyday life, and studying its association with outcome after Tx has recently been 
suggested (Denny et al., 2012; Fredericks, 2012). More information on childhood 
HRQOL and PSA, as well as on risk factors for poorer outcome is therefore needed to 
plan interventions to improve long-term outcome after pediatric Tx. 
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2 AIMS OF THE STUDY 
 
This thesis addressed cognitive and behavioral outcome in school-aged children who 
have undergone a heart, kidney, or liver Tx. In addition, this thesis analyzed medical, 
neurological, and social risk factors for poorer outcome. 
 
Studies I-III aimed to provide a comprehensive neuropsychological profile of children 
with a heart, kidney, or liver Tx. A series of standardized psychological tests served to 
assess global intelligence, attention, language, sensorimotor and visuospatial functions, 
memory and learning, and social processing. Additionally, parents completed a 
questionnaire on their child’s development. 
 
Study IV aimed to evaluate self-reported HRQOL and PSA in pediatric organ Tx 
recipients. Additionally, parents and teachers completed a questionnaire on the child’s 
PSA. 
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3 METHODS 
3.1 Subjects 
3.1.1 The transplant group 
 
All pediatric organ Tx in Finland are performed at the Helsinki University Central 
Hospital, where the pediatric Tx patients also attend annual medical follow-up. 
Children included in this study had undergone kidney or liver Tx at least one year or 
heart Tx at least three months prior to assessment, attended medical follow-up at the 
Helsinki University Central Hospital, were between 6.0 and 16.5 years of age (born 
between March 1991 and September 2003), and had Finnish or Swedish as their first 
language. A total of 19 heart, 59 kidney, and 22 liver Tx children across Finland met 
the inclusion criteria. Children with an acute clinical condition (one kidney and one 
liver Tx patient) or severe neurological comorbidity interfering with assessments (one 
kidney Tx patient) were excluded. One kidney Tx patient was unable to complete the 
assessments due to psychological distress. Six kidney Tx patients (8-16 years of age) 
declined to participate. Of these, one had neurological comorbidity, two had psychiatric 
comorbidity, and one had both. Three liver Tx patients in their teens (12-14 years of 
age) declined to participate; their medical records revealed that all had normal 
neurological and psychiatric outcome. All of the heart Tx patients elected to participate. 
Altogether 19 heart, 50 kidney, and 18 liver Tx recipients participated in Studies I-
III, yielding participation rates of 100%, 89%, and 86%, respectively. Diseases leading 
to heart Tx were: cardiomyopathy (n = 12; 63%) and CHD (n = 7; 37%); to kidney Tx: 
CNF (n = 22; 44%), polycystic kidneys (n = 5; 10%), renal dysplasia (n = 4; 8%), 
urethral valve (n = 4; 8%), and other diagnoses representing several individual diseases 
(n = 15; 30%); and to liver Tx: biliary atresia (n = 7; 39%), acute hepatitis (n = 3; 
17%), and other diagnoses (n = 8; 44%). The patients received their transplants 
between 1993 and 2008. All kidney Tx children had received dialysis prior to Tx (2 
hemodialysis, 46 peritoneal dialysis, and 2 both). Five patients had undergone a re-Tx: 
two kidney Tx children (4 and 13 years post-Tx) and one liver Tx child (1 month post-
Tx). Two patients who had first received a kidney Tx later underwent a combined liver-
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kidney Tx (2 and 6 years post-Tx). Information from the first Tx served as background 
variables, with the exception of follow-up time (second Tx), total time on dialysis, and 
waiting time (first + second Tx). Thus, the study assessed important risk factors (i.e., 
Tx at an early age, long waiting time, and short follow-up time) suggested in the 
existing literature. Disease duration, however, refers only to the first Tx, since the 
medical records were usually ambiguous about when disease recurred. In total, five 
patients received a combined liver-kidney Tx and one patient a combined heart-lung 
Tx. All liver Tx and 39 (78%) kidney Tx patients received a deceased donor’s organ. 
Detailed characteristics of the patients appear in Table 1. Despite the Tx of different 
organs, the patients had received similar treatment (e.g., triple therapy immuno-
suppression with cytokine inhibitors [cyclosporine or tacrolimus], antimetabolites 
[azathioprine or mycophenolate mofetil], and steroids [methylprednisolone]) at the 
same center. 
Children who underwent complete neuropsychological assessment in Studies I-III 
were recruited to Study IV. Because of differences in study designs, the inclusion 
criteria differed slightly. Because Study IV compared Tx groups, it excluded children 
who received a combined liver-kidney Tx (n = 5 in Study II and n = 4 in Study III). 
Additionally, two children in Study I were assessed less than six months (3 months and 
5 months) after heart Tx. To achieve more uniform inclusion criteria between Tx 
groups, these children were excluded from Study IV. Further, one heart and one kidney 
Tx patient declined to participate. Thus, a total of 74 eligible Tx patients (16 heart, 44 
kidney, 14 liver) participated in Study IV. 
In Studies I-III, one kidney Tx child exceeded the age criteria for the Wechsler 
Intelligence Scale for Children, 3rd edition (WISC-III; Wechsler, 1999), and one patient 
in each Tx group declined to undergo neuropsychological assessment with the NEPSY-
II: A Developmental Neuropsychological Assessment (NEPSY-II; Korkman, Kirk, & 
Kemp, 2008). Of the 82 patients between 5 and 15 years of age, 17 heart (94%), 38 
kidney (81%), and 15 liver (88%) Tx patients returned the parental evaluation of 
developmental problems with the Five to Fifteen questionnaire (Korkman et al., 2005). 
Of the 74 participants in Study IV, 66 (89%) completed a 15D-17D HRQOL self-
assessment. Altogether 70 parents (95%), 35 of 42 patients over 10 years of age (no 
self-assessment was available for younger children; 83%), and 61 of 72 eligible 
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teachers (85%) completed questionnaires on the patients’ PSA. Of the parents, 65 
mothers (88%) and 62 fathers (84%) completed the HRQOL self-assessment. Some 
subjects lacked assessment of parental HRQOL; consequently, regression analyses of 
PSA included 57 parent reports, 30 youth reports, and 50 teacher-reports. Regression 
analyses of HRQOL included 65 patients. No significant differences in the participation 
rates emerged in HRQOL and PSA assessments between the Tx groups. 
 
3.1.2 The control group for neuropsychological assessment 
 
A control group was formed for each Tx group from a large standardization sample in 
which 923 Finnish children aged 3 to 15 years were assessed individually with NEPSY-
II (Korkman et al., 2008). Data were collected during the years 2007 and 2008. These 
children underwent no WISC-III evaluation and completed no questionnaires. For each 
child with Tx, one index child of the same gender, age (within 6 months), and mother’s 
level of education (four levels: comprehensive school, secondary level, lower and 
higher tertiary level) was randomly chosen. Education was classified according to the 
United Nations Educational, Scientific and Cultural Organization International 
Standard of Education, which has been applied for Finnish conditions (Official 
Statistics of Finland, 1997). In the standardization project, older children were assessed 
every second year; consequently, the sample comprised children aged 9 ± 2 months, 11 
± 2 months, 13 ± 2 months, and 15 ± 2 months. Therefore, no matches were found 
based on age in seven heart, seven kidney, and two liver Tx children, and the groups 
were treated as a group rather than as individual case-by-case matches. 
The Tx groups and their respective control groups were comparable with respect to 
age (p = .989 for heart, p = .829 for kidney, p = .904 for liver Tx). Equal numbers of 
girls and boys were included. Similarly, mother’s level of education was matched in all 
groups, except for one heart Tx patient for whom no index child could be found to 
match the mother’s education. Although not a matching criterion, father’s level of 
education did not differ between the groups (p = .136 for heart, p = .053 for kidney, p = 
.423 for liver Tx). The kidney Tx group revealed a trend toward lower education level 
among fathers compared to the control group. 
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Table 1. Background characteristics for the 87 transplant patients who participated in the study 
  Heart 
  (n = 19) 
 Kidney 
  (n = 50) 
Liver 
  (n = 18) 
p 
Demographic and social data     
Gender:  
male, n (%) 
female, n (%) 
  
8 (42%) 
11 (58%) 
 
28 (56%) 
22 (44%) 
   
       7 (39%) 
     11 (61%) 
.375a 
Mother’s education, n (%)b 
Lower and higher secondary  
Lower and higher tertiary 
 
   12 (67%) 
     6 (33%) 
 
   33 (67%) 
   16 (33%) 
 
  14 (82%) 
        3 (18%) 
.515a 
Father’s education, n (%)b 
Lower and higher secondary  
Lower and higher tertiary 
 
   12 (67%) 
     6 (33%) 
 
   30 (73%) 
   11 (27%) 
 
  12 (80%) 
     3 (20%) 
.682a 
Child not living with both 
biological parents, n (%)c 
     2 (13%)    15 (36%)       5 (38%) .219a 
Pre-transplantation data     
Premature birth, gestational 
week < 37 
     2 (11%)    16 (38%)      4 (27%) .120a 
Congenital disease, n (%)    11 (61%)    46 (92%)     13 (72%) .010a 
Age at inclusion on the 
waiting list for Tx, years 
5.8 ± 4.1 
 0.8–15.3 
2.9 ± 3.4 
  0.4–13.0 
3.9 ± 4.6 
  0.0–14.2 
.008d 
Waiting time for Tx, days 223.3 ± 420.7 
     4.0–1762.0 
290.5 ± 269.4 
    17.0–1067.0 
102.4 ± 118.1 
    1.0–395.0 
.001d 
Disease duration prior to Tx, 
years 
 
4.2 ± 4.1 
0.06–15.3 
3.3 ± 2.8 
  0.7–10.7 
2.2 ± 3.4 
0.01–12.8 
.005d 
Transplantation data     
Age at first Tx, years 6.4 ± 4.3 
  1.0–15.3 
3.7 ± 3.5 
  0.7–13.4 
4.3 ± 4.4 
  0.7–14.4 
.027d 
Hospital stay after Tx, days    33.7 ± 9.6 
22.0–64.0 
30.9 ± 11.9 
18.0–64.0 
42.5 ± 18.1 
23.0–99.0 
.002d 
ICU stay after Tx, days 8.9 ± 5.6 
 2.0–22.0 
2.3 ± 0.8 
1.0–5.0 
5.4 ± 3.3 
  2.0–15.0 
< .001d 
Height at Tx, z-scoree    -1.1 ± 1.5 
    -4.1–0.6 
    -1.6 ± 1.6 
-9.0–0.7 
    -1.4 ± 1.8 
     -4.3–2.2 
.366d 
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Data at the time of assessment  
Age at assessment, years    12.0 ± 3.1 
  6.4–16.4 
     1.1 ± 3.2 
  6.3–16.4 
    11.8 ± 3.1 
  7.2–16.1 
.530d 
Follow-up time from the last 
Tx, years 
     5.5 ± 3.6 
  0.3–11.1 
6.9 ± 3.6 
  1.0–14.1 
 7.6 ± 4.5 
   1.0–15.0 
.243f 
Height at assessment, z-scoree     -0.9 ± 1.1 
     -3.3–0.6 
    -1.3 ± 1.1 
     -4.2–1.3 
-0.7 ± 1.1 
-3.4–0.8 
.086f 
Neurological comorbidity, n 
(%) 
     7 (37%)    17 (34%)       7 (39%) .749a 
Psychiatric diagnosis, n (%)c      3 (19%)    11 (25%)       5 (36%) .615a 
Immunosuppression: 
cyclosporine, n (%) 
tacrolimus, n (%) 
 
    15 (79%) 
     4 (21%) 
 
   24 (48%) 
   26 (52%) 
 
    13 (72%) 
      5 (28%) 
 
.029a 
 
Mother’s HRQOL scoreg      .96 ± .04 
      .86–1.0 
      .94 ± .06 
       .77–1.0 
 .95 ± .05 
 .86–1.0 
.577d 
Father’s HRQOL scoreg      .94 ± .05 
      .87–1.0 
      .97 ± .03 
       .86–1.0 
 .97 ± .03 
 .92–1.0 
.074d 
HRQOL, health-related quality of life; ICU, intensive care unit; Tx, transplantation. 
Note. Data presented as mean ± standard deviation and range, unless otherwise specified. Four children 
with a combined liver-kidney Tx are included in both the kidney and liver groups. Some information was 
missing for one liver Tx child who underwent Tx abroad. Due to more stringent inclusion criteria in 
Study IV, the patient groups were smaller than in Studies I-III. The results remained the same, however, 
except for two variables. Height at assessment (p = .013) became significant, with kidney Tx children 
being significantly shorter than liver Tx children (p = .027). Additionally, age at Tx became non-
significant (p = .102). The direction of the results was the same, however. 
aExact χ2-test 
bOnly children who had undergone neuropsychological assessment with the NEPSY-II were included. 
Information on the father’s education was missing for eight kidney and two liver Tx children. 
cOnly children participating in Study IV were included. Information on family structure lacked for two 
kidney and one liver Tx children. 
dKruskal-Wallis test 
ez-score = (observed height  mean height for age) / standard deviation (Pere, 2000). When children who 
had undergone growth hormone treatment after Tx (n = 16) were excluded from the analysis of height at 
assessment, the results remained consistent. 
fAnalysis of variance 
gOnly children participating in Study IV were included. A lower HRQOL score indicates more problems. 
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All children in the control group attended school with a normal curriculum, and none 
had any neurological diagnoses. All spoke Finnish as their first language, whereas nine 
children in the Tx group spoke Swedish as their first language or were bilingual 
Finnish-Swedish speakers and were assessed in Swedish. Analyses were performed 
with and without the results of these nine children. Because the results did not change, 
the results for these children were kept in the final analyses. 
 
3.2 Cognitive and behavioral outcome variables 
 
The psychological assessments used in this study appear in Table 2. A shortened 
version of the Finnish WISC-III (Wechsler, 1999) was used to evaluate global 
intelligence (WISC-IV was unavailable in Finnish). Specific subtests were selected 
because they had a high correlation with VIQ and PIQ. A Full-Scale IQ (FSIQ) of 85 or 
above (≥ -1 standard deviation; SD) was considered an average range of performance, 
70-84 (-2 SD ≤ FSIQ < -1 SD) was borderline, and below 70 (< -2 SD) was 
significantly below average. These cutoffs agree with the ICD-10 classification of 
mental retardation (IQ < 70) and are generally used in pediatric Tx research. 
Specific neuropsychological assessment was undertaken with NEPSY-II (Korkman, 
Kirk, & Kemp, 2007a; Korkman et al., 2008), a test comprising 29 subtests in six 
domains of development. The present study used the Finnish standardization version of 
the test. According to the test manual, the selection of subtests is based on the child’s 
age and clinical needs. In this study, ten subtests were selected to provide a 
comprehensive profile across all domains. According to the NEPSY-II manual, a 
standard score of eight or above (> -1 SD) represented an average range of 
performance, a standard score of six or seven (-1 SD to -1⅓ SD) was borderline, and a 
standard score of five or below (< -1⅓ SD) was below average (Korkman, Kirk, & 
Kemp, 2007b). This is a more stringent classification than the one used for WISC-III in 
this study.  
Parents also completed the Five to Fifteen questionnaire on developmental problems 
(Korkman et al., 2005). Lower scores indicate better outcome. The cutoff point for 
significant difficulties was set according to manual instructions at ≥ 90th percentile. 
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Table 2. Psychological assessments used in the study 
Neurocognitive tests 
Wechsler Intelligence Scale for Children, 3rd edition (WISC-III; Wechsler, 1999) 
Information, Similarities, Comprehension (Verbal Intelligence Quotient) 
Picture Completion, Picture Arrangement, Block Design (Performance Intelligence Quotient) 
 
NEPSY-II (Korkman, Kirk, & Kemp, 2008) 
Auditory Attention and Response Seta (Attention and Executive Functions domain) 
Speeded Naming, Comprehension of Instructions (Language domain) 
Visuomotor Precision (Sensorimotor Functions domain) 
Memory for Designs, Memory for Faces, Word List Interference (Memory and Learning 
domain) 
Design Copying, Geometric Puzzles (Visuospatial Processing domain) 
Affect Recognition (Social Perception domain) 
 
Questionnaires 
Five to Fifteen (Korkman et al., 2005) 
Self-reported health-related quality of life (HRQOL) questionnaire 
17D for ages 8-11 (Apajasalo, Rautonen et al., 1996) 
16D for ages 12-15 (Apajasalo, Sintonen et al., 1996) 
15D from age 16 (Sintonen, 2001) 
Achenbach System of Empirically Based Assessment (ASEBA; Achenbach & Rescorla, 2001) 
Child Behavior Checklist for parents 
Youth Self-Report for ages 11-16 
Teacher’s Report Form 
aThe Auditory Attention and Response Set is one subtest, although it yields two scores: one for Auditory 
Attention and another for the Auditory Attention and Response Set. 
 
HRQOL was evaluated with the self-assessment questionnaires appropriate for age: 
17D© for preadolescents ages 8-11, 16D© for adolescents ages 12-15, and 15D© for 
those above 15 years (Apajasalo, Rautonen et al., 1996; Apajasalo, Sintonen et al., 
1996; Sintonen, 2001). The contents of the three questionnaires overlap considerably. 
They consist of 15-17 multiple-choice questions, each representing one health-related 
dimension: mobility, vision, hearing, breathing, sleeping, eating, speech, excretion, 
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discomfort and symptoms, school and hobbies/usual activities, vitality, depression, 
distress, concentration (17D), learning and memory (17D), friends (16D-17D), 
appearance (16D-17D), mental function (15D-16D), and sexual activity (15D). The 
instruments can be used both as a profile and a single health utility index (the HRQOL 
score, range 0-1), which are generated using a set of population preference or utility 
weights. Higher scores indicate better HRQOL (1 = full health). Scores across the 
different dimensions vary in the general population. For children under the age of eight, 
the 17D questionnaire was postponed until they met the age requirements. 
PSA was evaluated with the Achenbach System of Empirically Based Assessment 
(ASEBA®) completed by the patients themselves, their parents, and teachers 
(Achenbach & Rescorla, 2001). These questionnaires form eight syndrome scales: 
Anxious/Depressed, Withdrawn/Depressed, Somatic Complaints, Social Problems, 
Thought Problems, Attention Problems, Rule-Breaking Behavior, and Aggressive 
Behavior. These are compiled into three summary scores: Total Problems from all the 
syndrome scales, Internalizing Problems from the first three syndrome scales, and 
Externalizing Problems from the last two syndrome scales. All of these have a mean T-
score of 50 (SD 10); lower scores indicate better PSA. Cutoff points for clinical 
problems were set according to manual instructions at > 90th percentile or a T-score of 
> 63 (borderline range 84th-90th percentile or T 60-63) for the summary scales and at > 
97th percentile or T > 69 (borderline range 93rd-97th percentile or T 65-69) for the 
syndrome scales.  
In addition, both the mothers and fathers completed the 15D questionnaire by 
assessing their own perceived health and wellbeing (Sintonen, 2001). The measurement 
served to ensure that the Tx groups showed no differences with respect to parental 
wellbeing and to analyze the effect of parental wellbeing on the child’s PSA.  
 
3.3 Background and medical variables 
 
The parents also completed a form on background variables, which included special 
education services received by the child, family structure, and parental education level 
(Table 1). Because of small sample sizes, in risk factor analyses, parental education 
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was merged into two categories: lower and higher secondary education versus lower 
and higher tertiary education.  
Information on medical variables, neurological risk factors, and psychiatric 
diagnosis came from the patients’ medical records (Table 1). Neurological 
comorbidities included sensory impairment; pre- and perinatal, neurological, and 
neurosurgical complications; and severe post-Tx complications with possible brain 
insult (Table 3). These were diagnosed by a clinician either before or after Tx. This 
classification of neurological comorbidity was used in Studies II and IV. An additional 
analysis was undertaken for the liver Tx group using this same classification, because 
no neurological risk group analysis had been performed in Study III. In Study I, 
classification of neurological comorbidity was based on brain imaging findings before 
heart Tx. Due to significant neurological symptoms, five children underwent brain 
magnetic resonance imaging and one child a computed tomography scan prior to heart 
Tx. Two of these patients had suffered brain infarction, presenting with left-sided 
hemiparesis. One patient with delayed motor development and hypotonicity, who was 
later diagnosed with mild mental retardation and ataxia, was found to have cerebellar 
atrophy and changes in the white matter in the lateral ventricles. One patient suffering 
from seizures and headaches had a cerebellar ischemic lesion and hypertensive 
encephalopathy. In addition, two patients had each had a brain abscess that was 
successfully treated. One of them exhibited left-sided hemiparesis and seizures before 
treatment; later, an infarct occurred in the middle cerebral artery with ischemic changes 
in the external capsule that caused hemiparesis lasting one day. The symptoms of the 
other patient with abscess are unknown. These six patients and one patient born 
extremely prematurely (gestational week 25) formed the neurological risk group in 
Study I. Further, diagnostic subgroups within each organ Tx group were for statistical 
purposes categorized into two groups, based on their major diagnoses (in heart CHD vs. 
cardiomyopathy; in kidney CNF vs. other; in liver biliary atresia vs. other). 
The following additional medical variables were recorded: bypass time during heart 
Tx and previous corrective heart surgeries (yes/no) in heart Tx patients, time on 
dialysis prior to kidney Tx, highest bilirubin level prior to liver Tx, and graft function at 
the time of assessment (Appendix 1). All heart and liver Tx patients exhibited normal 
graft function. However, all patients with a kidney Tx exhibited weakened kidney 
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function; 19% had values near normal (glomerular filtration rate > 60 ml/min per 1.73 
m2) and 81% below normal (glomerular filtration rate ≤ 60 ml/min per 1.73 m2). 
Deteriorating kidney function in long-term follow-up is a normal finding (Ortiz et al., 
2005). However, all participants exhibited stable graft function with no impact on 
general health. For a comparison of patients with CNF and other kidney diseases, 
weight and height at birth, weight at Tx, and weight at the time of assessment were also 
recorded. These variables have shown a decrease in children with CNF (Jalanko, 2009). 
 
Table 3. Description of 29 children with neurological comorbidity or severe risk factors 
Comorbidity / Risk factor n 
Pre- and perinatal  
Alcohol exposure in utero with clinical sequelae 2 
Birth at very low gestational age < 32 weeks (one with hearing impairment)  2 
Severe asphyxia (one born at gestational week 25, two with cerebral palsy)  3 
Neurological  
Diagnosis of mental retardation 4 
Hemiparesis 4 
Syndromes: one unspecified involving dysmorphic features and one G-protein  
signaling disorder with damage to several organs 
2 
Epilepsy 2 
Neurosurgical  
Shunt due to increased intracranial pressure and hearing impairment (one with  
Townes-Brocks syndrome, one idiopathic) 
2 
Brain abscess, successfully treated 2 
Neurosurgery due to Chiari 1 malformation 1 
Sensory impairment  
Severe visual impairment 1 
Hearing impairment 1 
Post-transplantation risks  
Hypertensive encephalopathy 2 
Hypertensive crises with pulmonary edema treated at the intensive care unit 1 
Note. The table shows only each patient’s most severe comorbidity or risk factor. The same patients 
may, however, exhibit other risks as well. These were diagnosed by a clinician either before or after 
transplantation. One single seizure was not considered a neurological sequela.  
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3.4 Procedure 
 
The children were recruited for the study during their annual visit at the Helsinki 
University Central Hospital or an appointment was made by telephone to assess the 
child at the hospital closest to the patient’s home. The author and two trained 
undergraduate research assistants performed the neuropsychological assessments 
between May 2007 and September 2009. Parents received written feedback on the 
neuropsychological assessment. If problems were found, the family was referred to a 
psychologist in their hometown. 
The patients and their caregivers received the questionnaires when they arrived for 
their appointment for the neuropsychological assessments and returned the completed 
questionnaires in a pre-addressed, pre-paid envelope. The questionnaires were 
distributed by researchers (Haavisto and Qvist) who were uninvolved in the patients’ 
clinical care. Questionnaires were collected until December 2010.  
The research plan was approved by the Ethics Committee of the Helsinki University 
Central Hospital in April 2007. Written consent was obtained from one caregiver of 
each child. Additionally, children aged 15 and older provided their own written 
consent. 
 
3.5 Statistical analyses 
 
Statistical calculations were carried out using IBM SPSS Statistics 18.0.3 software. 
Graphical histograms and the Kolmogorov-Smirnov test of normality were used to 
analyze whether any variables deviated from a normal distribution. Background 
variables between two groups were compared using the independent samples t-test for 
normally distributed continuous variables and the Mann-Whitney U-test for non-normal 
distributions. Background variables between three groups were compared using 
analysis of variance (ANOVA) for normally distributed variables and the Kruskal-
Wallis test for non-normal distributions, with Bonferroni corrected post hoc tests. An 
exact χ2-test was used to compare categorical data. 
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In Studies I-III on cognitive outcome, WISC-III and NEPSY-II scores were in age-
corrected standard scores. The WISC-III scores in each Tx group were compared to test 
norms with the Student’s one-sample t-test (Wechsler, 1999). An additional analysis 
was undertaken to analyze within-group PIQ-VIQ discrepancies using the paired-
samples t-test. For the NEPSY-II, missing observations (< 5%, range 0-3) were 
estimated with the expectation-maximization algorithm (Dempster, Laird, & Rubin, 
1977). A profile analysis was carried out in each Tx group using mixed ANOVA with 
the group (Tx vs. control group) as the between-subjects factor, the NEPSY-II subtest 
as the within-subjects factor, and the subtest standard score as the dependent variable, 
thereby enabling comparison of the groups’ neuropsychological test profiles 
(Tabachnick & Fidell, 2007). An additional analysis was undertaken with the Student’s 
one-sample t-test to compare NEPSY-II scores to the test norms (Korkman et al., 
2008). Bonferroni correction was calculated by multiplying each p-value by the number 
of comparisons (11). Outcome in patients with neurological comorbidity and organ-
specific diagnostic subgroups was analyzed with the independent samples t-test for 
WISC-III and mixed ANOVA for NEPSY-II, as described above. An exact χ2-test was 
used to compare the Five to Fifteen questionnaire percentile classes with expected 
values for the questionnaire norms (Korkman et al., 2005).  
Risk factors for cognitive outcome were analyzed using the Pearson or Spearman 
correlation coefficient, as appropriate. The following variables were used in bivariate 
correlations with VIQ, PIQ, and NEPSY-II domain scores: parental education, 
congenital disease (yes/no), prematurity (< 37 weeks of gestation), disease duration, 
age at Tx and at assessment, follow-up time, as well as bypass time and corrective heart 
surgeries in heart Tx, time on dialysis and kidney function at the time of assessment in 
kidney Tx, and highest pre-Tx bilirubin level in liver Tx. A mixed ANOVA and the 
Mann-Whitney U-test were undertaken to analyze the effect of gender. 
In Study IV on behavioral outcome, comparisons of 15D-17D HRQOL utility index 
scores between Tx groups were undertaken with analysis of covariance, adjusted for 
disease duration and follow-up time. Disease duration varied significantly between Tx 
groups (Table 1) and was significantly associated with PSA. Follow-up time was 
significantly associated with the utility index as well as theoretically considered an 
important modifier for outcome. 
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Further, the 15D-17D HRQOL questionnaire data were compared to population 
norm data consisting of representative, age-standardized samples of the Finnish general 
population collected for the questionnaire norms (n = 239 for 16D and n = 244 for 17D; 
Apajasalo, Rautonen et al., 1996; Apajasalo, Sintonen et al., 1996). A mixed ANOVA 
was undertaken with the group (Tx vs. general population) as the independent between-
subjects factor, the 16D or 17D dimensions as the within-subjects factor, and the 
dimension scores as the dependent variable, thereby enabling comparison of the 
groups’ HRQOL profiles. Additionally, 16D and 17D index scores were compared 
between preadolescent and adolescent Tx patients using the Mann-Whitney U-test. 
ASEBA summary indices of PSA were in T-scores based on norms for children of 
the same age range and gender. Because Finnish norms were unavailable, U.S. norms 
were used. According to previous research, the test structure is similar between 
different cultures, including Finland and North America (Ivanova, Achenbach, 
Rescorla, Dumenci, Almqvist, Bathiche et al., 2007; Ivanova, Achenbach, Rescorla, 
Dumenci, Almqvist, Bilenberg et al., 2007; Ivanova, Dobrean et al., 2007). 
Comparisons of PSA between the Tx groups were undertaken with multivariate 
analysis of variance. The T-scores of the syndrome scales are truncated at a T-score of 
50. In order to account for the full range of variation, raw scores were used for all 
analyses, adjusted for gender and age range (< 11 years vs. ≥ 11 years), as 
recommended in the manual instructions (Achenbach & Rescorla, 2001). Additionally, 
all analyses between the Tx groups were adjusted for disease duration and follow-up 
time.  
Because no control group was available, T-scores of the PSA summary scores were 
compared to the questionnaire norms with the Student’s one-sample t-test. 
Additionally, an exact χ2-test was used to compare the summary and syndrome scale 
percentile classes with the expected values for the questionnaire norms (Achenbach & 
Rescorla, 2001). For both analyses, Bonferroni correction was calculated by 
multiplying each p-value by the number of comparisons.  
Risk factors that have previously been associated with outcome or that were 
theoretically of interest were analyzed using the Pearson or Spearman correlation 
coefficient, as appropriate. These risk factors included gender, parental education, child 
not living with both biological parents (yes/no), congenital disease (yes/no), disease 
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duration, age at Tx and at assessment, follow-up time, neurological comorbidity 
(yes/no), psychiatric diagnosis (yes/no), parental HRQOL (the 15D score), height at 
assessment, and type of immunosuppressant (cyclosporine vs. tacrolimus). Variables 
that correlated significantly (p < .05) with one or more of the ASEBA summary scores 
or the HRQOL score were included in a multiple regression analysis. The absolute 
values for these correlations ranged between .258 and .427. Congenital disease, follow-
up time, age at assessment, neurological comorbidity, psychiatric diagnosis, and child 
not living with both biological parents were entered as background variables for 
HRQOL. Disease duration, follow-up time, neurological comorbidity, psychiatric 
diagnosis, child not living with both biological parents, and mother’s and father’s 
HRQOL were entered as background variables for PSA. Different modeling methods 
were used (forward, backward, stepwise) due to multicollinearity. The results were the 
same, except that the background variables, which only showed a trend, were often 
excluded in the stepwise and forward analyses; the rest of the variables showed a 
stronger association with outcome. Backward analyses are presented. 
All tests of significance were two-tailed (p < .05). Partial eta-squared (p2) and R2 
served as indicators of effect size. In p2, .01 represents a minimal effect, .06 a medium 
effect, and  .14 a large effect size (Cohen, 1988). The Bonferroni correction for 
multiple comparisons was used for all ANOVAs, analysis of covariance, and 
multivariate analysis of variance. 
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4 RESULTS 
4.1 Cognitive outcome (Studies I-III) 
4.1.1 Intelligence 
 
The cognitive performance of the Tx groups on the WISC-III was compared to the test 
norms (Table 4). Mean FSIQs of the heart and kidney Tx children were significantly 
lower than expected, compared to the test norms, and fell in the borderline or near 
borderline range. As many as 42% of the heart and kidney Tx children had FSIQs in the 
borderline or below average range, compared to 16% in the standardization sample 
(Table 5). The mean VIQs of the heart and kidney Tx children were in the low-average 
range, and PIQs in the borderline range. Liver Tx children had FSIQ and VIQ within 
average, yet their PIQ was significantly lower than expected, compared to the test 
norms, and fell in the low-average range. 
In general, Tx children tended to have lower scores in PIQ compared to VIQ (t(18) = 
-1.80, p = .088 for heart; t(47) = -2.04, p = .047 for kidney; t(17) = -2.09, p = .052 for 
liver Tx). The lowest subtest scores in all Tx groups emerged in the subtest Block 
Design.  
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Table 5. Numbers (percentages) of transplant patients who performed in the average, 
borderline, and below-average range in the WISC-III and who received special education 
services according to parent-reports 
 Heart 
(n = 19) 
Kidney 
(n = 49) 
Liver 
(n = 18) 
WISC-III performance    
Average IQa 11 (58%) 28 (57%) 14 (78%) 
Borderline IQa   3 (16%) 12 (24%)   2 (11%) 
Below-average IQa   5 (26%)   9 (18%)   2 (11%) 
PIQ < VIQb   6 (32%) 17 (35%)   5 (28%) 
Educational interventions    
Full-time special educationc   3 (16%) 10 (20%)   3 (17%) 
Part-time special educationc   5 (26%)   7 (14%)   3 (17%) 
Part-time special education in mathc   3 (16%)   6 (12%)   3 (17%) 
IQ, intelligence quotient; PIQ, performance IQ; VIQ, verbal IQ. 
aIn the standardization sample, 13.6% performed in the borderline range and 2.3%, below 
average. 
bNumber of children with PIQ ≤ 15 standard scores lower than VIQ. 
cIn Finland, 8% of comprehensive school students attend full-time special education, and 
22% attend part-time special education. For 5% of students, the reason for transferring to 
special-education was a learning disability in mathematics. 
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4.1.2 Neuropsychological profile 
 
The NEPSY-II profiles of the different Tx groups were compared to their respective 
matched control groups (Table 6). A 2 × 11 mixed ANOVA with group as the between-
subjects factor, the NEPSY-II subtests as the within-subjects factor, and the subtest 
standard score as the dependent variable resulted in a significant and large main effect 
of group for all Tx groups (F(1,34) = 10.92, p = .002, p2 = .243 for heart; F(1,96) = 
24.25, p < .001, p2 = .202 for kidney; F(1,32) = 9.71, p = .004, p2 = .233 for liver). 
The test  group interaction indicated no difference in the shape of the test profiles 
between heart and liver Tx patients and their control groups (F(10,340) = 1.16, p = 
.320, p2 = .033 for heart; and Greenhouse-Geisser corrected F(7.2,231.7) = 1.41, p = 
.199, p2 =.042 for liver), but for kidney Tx children, the effect of group was not similar 
for all subtests (Greenhouse-Geisser corrected corrected F(8.3,792.3) = 2.25, p = .021, 
p
2 = .023). The Bonferroni corrected post hoc tests appear in Table 6. The heart Tx 
group had lower scores in the verbal tasks of Comprehension of Instructions and Word 
List Interference, the visuospatial tasks of Design Copying and Memory for Designs, 
and Affect Recognition. The kidney Tx group scored significantly lower than the 
control group across domains, except for visual memory. The liver Tx group had a 
specific profile of lower scores in the domains of Sensorimotor Functions, Visuospatial 
Processing, and Social Perception. The lowest subtest scores emerged in all Tx groups 
in Visuomotor Precision and Design Copying, which all fell in the borderline range.  
Because the scores of the matched control groups differed from the mean of the 
standardization sample, an additional analysis was conducted to compare the different 
Tx groups with the test norms. In the heart and liver Tx groups, only Visuomotor 
Precision and Design Copying differed significantly from the test norms (t(17) = -4.08, 
p = .011 and t(17) = -5.30, p < .001 for heart Tx; and t(16) = -3.43, p = .033 and t(16) = 
-3.89, p = .011 for liver Tx). In the kidney Tx group, a generalized effect across 
domains remained. However, Auditory Attention and Response Set became non-
significant, whereas Memory for Faces (t(48) = -3.43, p = .011) became significant. 
These results further underscore the visuomotor and visuoconstructive deficits observed 
in heart and liver Tx patients and the generalized effect in kidney Tx patients. 
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4.1.3 Groups with neurological risk factors 
 
In all Tx groups, a significant minority of patients had neurological comorbidity or 
neuroradiological findings. To compare patients who had neurological comorbidity and 
those who did not, an independent samples t-test was undertaken for WISC-III and a 2 
× 11 mixed ANOVA with group as the between-subjects factor, the NEPSY-II subtests 
as the within-subjects factor, and the subtest standard score as the dependent variable 
for NEPSY-II.  
In the heart Tx group, children with neuroradiological findings pre-Tx and one child 
with extreme prematurity (n = 7) scored lower than did children without neurological 
risk factors (n = 12) on the WISC-III (VIQ 76.6 ± 11.3 vs. 97.5 ± 24.4, p = .049; PIQ 
68.1 ± 18.4 vs. 90.3 ± 14.1, p = .009; and FSIQ 72.1 ± 13.4 vs. 93.5 ± 17.2, p = .012) 
and the NEPSY-II (F(1,16) = 6.36, p = .023, p2 = .284). However, the low-risk group 
also continued to score below test norms on PIQ (p = .037) and generally lower than 
the control group on the NEPSY-II (F(1,28) = 4.61, p = .041, p2 = .141). Bonferroni 
corrected post hoc tests revealed that the low-risk group scored lower than their 
matched control group on Design Copying (p = .039). Abnormalities on brain imaging 
were associated with the number of heart surgeries prior to Tx (U = 17.50, p = .016) 
and a diagnosis of CHD (2(1) = 5.70, p = .017). 
In the kidney Tx group, a significant minority of children had neurological 
comorbidity or risk factors diagnosed by a clinician either before or after Tx (n = 17). 
Patients with neurological comorbidity had significantly lower scores than did children 
without major neurological comorbidity (n = 33) on the WISC-III (VIQ 77.1 ± 25.0 vs. 
93.1 ± 18.4, p = .015; PIQ 63.9 ± 26.7 vs. 88.9 ± 17.2, p = .003; and FSIQ 69.2 ± 24.0 
vs. 90.6 ± 13.7, p = .005) and the NEPSY-II (F(1,47) = 5.16, p = .001, p2 = .099). 
However, children without neurological comorbidity also continued to score below test 
norms on the WISC-III (VIQ p = .038; PIQ p = .001; FSIQ p < .001) and generally 
lower than the control group on the NEPSY-II (F(1, 77) = 8.79, p = .004, p2 = .102). 
Bonferroni corrected post hoc tests revealed that kidney Tx children without 
neurological comorbidity scored lower than their matched control group on 
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Comprehension of Instructions (p = .006), Design Copying (p = .007), and Affect 
Recognition (p = .018).  
In the liver Tx group, children with neurological comorbidity or risk factors (n = 7), 
diagnosed either before or after Tx, did not differ significantly from patients without 
major neurological comorbidity (n = 11) on the WISC-III (VIQ 89.9 ± 20.7 vs. 105.7 ± 
18.9, p = .113; PIQ 82.6 ± 23.9 vs. 93.0 ± 19.8, p = .329; and FSIQ 85.9 ± 21.5 vs. 99.2 
± 14.4, p = .113) or the NEPSY-II (F(1,15) = 0.86, p = .368, p2 = .054). Children 
without neurological comorbidity continued to score lower than the control group on 
the NEPSY-II (F(1,26) = 5.00, p = .034, p2 = .161), specifically on Visuomotor 
Precision (p = .043), Design Copying (p = .020), and Affect Recognition (p = .007). 
 
4.1.4 Organ-specific diagnostic subgroups 
 
The cognitive outcome of the major diagnostic subgroups within the Tx groups were 
analyzed. Because of the small group sizes, no statistically significant differences 
emerged. However, some interesting trends were noted. For heart Tx, children with 
CHD did not differ significantly from children with cardiomyopathy, but a large effect 
size was observed in NEPSY-II (see Table 7 for WISC-III scores; F(1,16) = 3.05, p = 
.100, p2 = .160 for NEPSY-II). On average, children with CHD scored 11 points lower 
than children with an initial diagnosis of cardiomyopathy on FSIQ.  
Similarly for kidney Tx, children with CNF did not differ significantly from children 
with other kidney diseases (see Table 8 for WISC-III scores; F(1,47) = 1.72, p = .196, 
p
2 = .035 for NEPSY-II). Because we are unaware of other studies reporting the 
cognitive outcome of CNF children alone, a more detailed comparison of the groups 
was undertaken even though the group comparisons were non-significant. A trend 
toward better performance in PIQ occurred in patients with CNF, which approached 
significance (Table 8). Similarly, Bonferroni corrected post hoc tests revealed better 
scores for the CNF group in Design Copying and Geometric Puzzles, and the 
differences approached significance (7.2 ± 2.9 vs. 5.4 ± 3.6, p = .062 and 8.9 ± 3.3 vs. 
7.2 ± 3.4, p = .096, respectively). Of the non-CNF children, 86% had a congenital 
disease.  
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Table 7. Comparison of heart transplant patients with congenital heart disease (CHD) and 
patients with cardiomyopathy 
 CHD 
(n = 7) 
Cardiomyopathy 
(n = 11) 
      p 
Pre-transplantation data    
Disease duration prior to Tx, years 7.7 ± 4.7 2.2 ± 1.7 .021 
Waiting time for Tx, days 0.5 ± 0.9 0.7 ± 1.3 .761 
Brain abnormality          5 (71%)          2 (29%)   .013a 
Transplantation data    
Age at first Tx, years 7.7 ± 4.7 5.6 ± 4.1 .327 
Height at Tx, z-scoreb -1.4 ± 1.5 -0.85 ± 1.5 .422 
Bypass time during Tx, min 208.9 ± 75.2 158.4 ± 64.3 .147 
Data at the time of assessment    
Age, years 12.6 ± 3.1 11.9 ± 3.0 .626 
Follow-up time from the last Tx, years 4.8 ± 4.7 6.0 ± 3.0 .511 
Height, z-scoreb -1.2 ± 0.9 -0.6 ± 1.1 .248 
Cognitive performance    
Verbal IQ  82.4 ± 23.9 94.1 ± 21.8 .292 
Performance IQ 75.7 ± 15.4  85.9 ± 20.3 .267 
Full-scale IQ     78.7 ± 18.1 89.7 ± 18.7 .230 
CHD, congenital heart disease; IQ, Intelligence Quotient; Tx, transplantation. 
Note. Data presented as mean ± 1 standard deviation, unless otherwise specified, with p-values from 
the independent samples t-test. 
aExact χ2-test 
bz-score = (observed height  mean height for age) / standard deviation (Pere, 2000). When children 
who had undergone growth hormone treatment after Tx were excluded, the results remained consistent. 
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Table 8. Comparison of kidney transplant patients with congenital nephrosis of the Finnish type 
(CNF) and patients with other diagnoses 
 CNF (n = 22) Other (n = 28)     p 
Birth data 
Gestational age, weeks 
Height, cm 
Birth weight, kg  
Pre-transplantation data 
 
35.5 ± 2.3 
47.2 ± 3.0 
  2.5 ± 0.4 
 
 
     37.4 ± 2.3 
49.1 ± 2.2 
  3.3 ± 0.6 
 
 
.026 
.023 
< .001 
 
Disease duration prior to Tx, years   1.9 ± 0.9   4.3 ± 3.3 .001 
Time on dialysis, yearsa   1.5 ± 1.1   1.3 ± 1.2 .670 
Waiting time for Tx, daysa   386 ± 315   223 ± 213 .060 
Transplantation data    
Age at first Tx, years   1.9 ± 0.9   5.2 ± 4.1 < .001 
Height at Tx, z-scoreb  -1.2 ± 2.0  -1.9 ± 1.3 .140 
Weight for height index at Tx, %c   0.6 ± 8.5   12.5 ± 20.7 .009 
Data at the time of assessment    
Age, years 11.0 ± 3.4 11.3 ± 3.1 .742 
Follow-up time from the last Tx, years   8.2 ± 3.4   5.8 ± 3.5 .016 
Height, z-scoreb  -0.9 ± 0.9  -1.7 ± 1.1 .010 
Weight for height index, %c   0.6 ± 9.0   20.8 ± 35.3 .008 
Neurological comorbidity, n (%)       7 (32%)    10 (36%) 1.000d 
Cognitive performance    
Verbal IQ  89.3 ± 16.2  86.8 ± 25.6 .668 
Performance IQ  88.6 ± 20.4  75.3 ± 24.4 .050 
Full-scale IQ  88.4 ± 13.7  80.4 ± 23.5 .144 
CNF, congenital nephrosis of the Finnish type; IQ, Intelligence Quotient; Tx, transplantation. 
Note. Data presented as mean ± 1 standard deviation, unless otherwise specified, with p-values from the 
independent samples t-test. When children with CNF were compared in an additional analysis to children 
with other congenital diseases, the results remained consistent, except for three variables. Birth height (p = 
.073) and follow-up time (p = .061) changed from significant to nearly significant, while Performance IQ 
became significant (p = .032). 
aTotal time on peritoneal or hemodialysis. For patients with retransplants, time on dialysis and waiting 
time for Tx include both the first and second Tx. 
bz-score = (observed height  mean height for age) / standard deviation (Pere, 2000). When children who 
had undergone growth hormone treatment after Tx were excluded, the results remained consistent. 
c% = ratio of weight (kg) for height (cm) to the mean weight for height ratio in the normal population 
(Pere, 2000).  
dExact χ2-test 
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Liver Tx children with an initial diagnosis of biliary atresia did not differ from those 
with other diagnoses. They were comparable in both the WISC-III (FSIQ 92.3 ± 19.4 in 
biliary atresia vs. 94.0 ± 18.8 in other diagnoses, p = .858) and the NEPSY-II test 
profiles (F(1,15) = 1.12, p = .306, p2 = .070). Consequently, no comparisons of 
background variables were undertaken. 
 
4.1.5 Parental evaluation of development 
 
Five to Fifteen evaluations were compared to the questionnaire norms (Table 9). The 
results indicate a statistically significant increase in the frequency of various 
developmental and behavioral problems reported by parents of Tx children. Across Tx 
groups, more problems were reported in the domains of Motor Skills, Perception, 
Memory, and Emotional/Behavioral Problems. Heart Tx children had additionally 
pronounced problems in Language. Kidney Tx children had more problems across the 
domains. Liver Tx children had additionally more problems in Learning and Social 
Skills. 
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4.1.6 Risk factors for cognitive outcome 
 
The results of those background variables that correlated significantly with cognitive 
outcome appear in Table 10. The following background variables strongly 
intercorrelated: longer duration of kidney disease correlated with older age at Tx (rs = 
.967, p < .001) and with shorter follow-up time after Tx (rs = -.448, p = .001). 
Likewise, older age at Tx and shorter follow-up time correlated for all Tx groups (rs = -
.740, p < .001 for heart; rs = -.485, p < .001 for kidney; and rs = -.672, p = .002 for liver 
Tx).  
Only a few associations emerged between risk factors and cognitive outcome after 
heart Tx. Intelligence showed no significant association with any of the risk factors, yet 
a trend for poorer PIQ emerged in children who had undergone corrective heart 
surgeries pre-Tx. Similarly, corrective heart surgeries showed a significant association 
with lower scores in Executive Functions. Lower Visuospatial Processing was 
associated with congenital disease (both CHD and cardiomyopathy with congenital 
onset) and longer follow-up time.  
In kidney Tx patients, poorer kidney function showed a negative association with 
VIQ and Language functions, Executive Functions, as well as Memory and Learning. 
The highly intercorrelated variables of longer disease duration, older age at Tx and at 
assessment, and shorter follow-up time were also associated with cognitive outcome, 
particularly the IQ measures. 
In liver Tx patients, congenital disease and longer disease duration were strongly 
associated with lower PIQ. The strongly intercorrelated variables of older age at Tx and 
shorter follow-up time showed a negative association with Executive Functions, 
Memory and Learning, and Social Processing. 
Because Studies I-III did not control for gender, mixed ANOVAs were carried out 
for all Tx groups combined. No significant main effect of gender emerged, indicating 
that girls and boys had similar group mean performance (F(1,83) = .021, p = .885, p2 < 
.001 for WISC-III; F(1,82) = .075, p = .785, p2 = .001 for NEPSY-II). To determine 
whether one gender had more severe impairments, FSIQ and NEPSY-II domains that 
fell more than 2 SD below the test norms were counted for each child. No differences 
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emerged in the Mann-Whitney U-test, indicating that girls and boys had similar 
numbers of low scores (p = .447). 
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4.2 Behavioral outcome (Study IV) 
4.2.1 Health-related quality of life 
 
The HRQOL of heart, kidney, or liver Tx children was compared in an analysis of 
covariance with the group as the between-subjects factor and the 15-17D utility score 
as the within-subjects factor, adjusting for disease duration and follow-up time. No 
statistically significant difference in HRQOL emerged between the Tx groups (F(2,61) 
= 0.73, p = .485, p2 = .023). The mean HRQOL scores were .94 ± .05 for 13 heart, .92 
± .08 for 40 kidney, and .93 ± .07 for 13 liver Tx patients. Thus, further analyses were 
undertaken for all Tx groups combined.  
The HRQOL profiles of the Tx groups were compared to those of the general 
population in a mixed ANOVA with the group as the between-subjects factor, the 16D 
or 17D dimensions as the within-subjects factor, and the dimension scores as the 
dependent variable. In 17D, the preadolescent patients (8-11 years) had a significantly 
lower HRQOL score than did the general population (F(1,274) = 5.44, p = .020, p2 = 
.019). The test  group interaction indicated that the effect of group was not similar for 
all dimensions (Greenhouse-Geisser corrected F(10.8,2954.6) = 3.87, p < .001, p2 = 
.014). The Tx preadolescents were worse off in the dimensions of excretion (p < .001), 
eating (p < .001), and their state of health made it more difficult for them to make or be 
with friends (p = .002) or to attend school and engage in hobbies (p < .001). In 16D, the 
adolescents (12-15 years) scored on the level of the general population (F(1,270) = 
0.14, p = .710, p2 = .001). The test  group interaction indicated that the effect of 
group was not similar for all dimensions (Greenhouse-Geisser corrected F(10.0,2688.4) 
= 4.90, p < .001, p2 = .018). The Tx adolescents had significantly fewer self-reported 
feelings of distress (p = .010) and experienced more vitality (p = .002) than did the 
general population, but they also reported more problems with excretion (p < .001), 
mobility (p < .001), eating (p < .001), attending school (p = .001), and being with 
friends (p = .004).  
 Preadolescents, as a group, reported lower self-reported HRQOL than did adolescent 
patients (17D .91 ± .06 vs. 16D .94 ± .08, p = .002). Preadolescents were more likely to 
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have a congenital disease (91% vs. 70%, p = .030), were younger at Tx (2.5 ± 1.7 vs. 
5.3 ± 4.1, p = .007), and had a shorter follow-up time (5.7 ± 2.1 vs. 8.5 ± 4.2, p < .001). 
Fewer preadolescents had experienced a rejection episode (59% vs. 82%, p = .032). 
The groups did not differ in any other background variables. 
 
4.2.2 Psychosocial adjustment  
 
The PSA of heart, kidney, or liver Tx children was compared in multivariate analysis of 
variance with the group as the between-subjects factor and the ASEBA scores of 
Internalizing and Externalizing Problems as the within-subjects factors, adjusting for 
disease duration and follow-up time. No statistically significant differences in PSA 
emerged between the Tx groups (F(4,124) = 1.59, p = .180; Wilk’s λ = .905, ηp2 = .049 
for parent reports; F(4,56) = 0.57, p = .683; Wilk’s λ = .923, ηp2 = .039 for youth self-
reports; F(4,106) = 1.71, p = .154; Wilk’s λ = .883, ηp2 = .060 for teacher-reports). For 
mean T-scores, see Table 11. Further analyses were undertaken for all Tx groups 
combined. 
The Student’s one sample t-test revealed significantly more parent- and teacher-
reported Total and Internalizing Problems compared to the questionnaire norms (Table 
12). Despite this increase, mean scores fell in the normal range; the χ2-tests revealed an 
increased amount of problems in the clinically significant range only in parent-reported 
Total and Internalizing Problems. The increase in Internalizing Problems identified in 
parent reports is attributable mainly to significant Somatic Complaints in 24% of the 
patients. Compared to the norms, this is significantly more than expected (χ2(1) = 
25.23, p < .001). Parents also reported that their children had more Social Problems 
(χ2(2) = 14.89, p = .02) in the borderline range than was expected from the norms. 
Youth self-reports did not differ from the questionnaire norms.  
Parent- and self-reports showed a moderate correlation (r = .677, p < .001 and r = 
.482, p = .003 for Internalizing and Externalizing Problems, respectively), as did 
parent- and teacher-reports (r = .451, p < .001 and r = .366, p = .004). Teacher- and 
self-reports showed no significant correlation (r = .159, p = .401 and r = -.067, p = 
.724).  
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Table 12. Mean T-scores ± 1 standard deviation on psychosocial adjustment for transplant 
patients compared to the ASEBA questionnaire norms, with t- and p-values from the Student’s 
one-sample t-test, as well as numbers (percentages) exceeding the cutoff for clinical problems, 
with χ2- and p-values from comparisons with the expected distribution based on the 
questionnaire norms 
 T-score t   p Clinical 
problems 
χ2 pa 
Parent-reported Child Behavior Checklist (n = 70)     
Internalizing Problems 55.5 ± 10.5 4.34 < .001 20 (29%) 26.83 < .001 
Externalizing Problems 51.8 ± 10.1 1.51 .136 11 (16%) 2.54 .158 
Total Problems 53.6 ± 10.5 2.89 .015 15 (21%) 10.16 .009 
Youth Self-Report (n = 35)       
Internalizing Problems 51.5 ± 9.8 0.92 .365   4 (11%) 0.08 1.000 
Externalizing Problems 51.6 ± 8.7 1.09 .283   4 (11%) 0.08 1.000 
Total Problems 52.3 ± 8.5 1.56 .127   4 (11%) 0.08 1.000 
Teacher Report Form (n = 61)       
Internalizing Problems 53.2 ± 9.3 2.68 .027   7 (11%) 0.15 .831 
Externalizing Problems 50.9 ± 7.9 0.85 .400 3 (5%) 1.75 .209 
Total Problems 54.5 ± 6.9 5.06 < .001 3 (5%) 1.75 .209 
ASEBA, The Achenbach System of Empirically Based Assessment. 
Note. The ASEBA questionnaires have a mean of 50 (standard deviation = 10). A lower score 
indicates better psychosocial adjustment. The cutoff point for clinical problems is T > 63 (> 90th 
percentile).  
aP-values for exact χ2-tests are reported. 
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4.2.3 Risk factors for behavioral outcome 
 
Since no significant differences between the Tx groups emerged, regression analyses 
were conducted for all Tx groups combined. For the self-reported HRQOL utility score, 
shorter follow-up time, acquired disease, psychiatric diagnosis, and neurological 
comorbidity accounted for 34% of the variance (Table 13). Risk factors associated with 
PSA differed depending on the rater (Table 14). PSA problems were associated with 
neurological comorbidity, parental HRQOL, family structure, and shorter follow-up 
time. Additionally, in teacher-reports, longer disease duration was associated with 
poorer PSA. Overall, associations between PSA and background variables were not 
high, especially not for self-reports.  
The most impaired syndrome scale, namely parent-reported Somatic Complaints, 
was analyzed separately; it was associated with shorter follow-up time (adjusted R2 = 
.086, p = .014).  
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Table 13. Multiple regression analysis of variables associated with self-reported health-related 
quality of life (15D-17D scores) 
Variable B 95% CI for B β Adjusted R2 
    .340 
Follow-up time  0.007 0.003, 0.011  .363**  
Psychiatric diagnosisa -0.059 -0.094, -0.024 -.355**  
Congenital diseasea -0.053 -0.090, -0.015 -.308**  
Neurological comorbiditya -0.028 -0.060, -0.004 -.186†  
Note. The model excluded the non-significant variables child not living with both parents and 
age at assessment. The analyses included 65 patients. A lower score in the 15D-17D 
questionnaires indicates more problems. **p < .01, *p < .05, †p < .10 
aCongenital disease, neurological comorbidity, and psychiatric diagnosis were coded as 
dichotomous variables. In all cases, 0 represents patients without a congenital disease and 
patients without neurological or psychiatric comorbidity; 1 represents the presence of these risk 
factors. 
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5 DISCUSSION 
 
The aim of this thesis was to report the cognitive and behavioral outcome of a 
national sample of pediatric organ Tx recipients in Finland, without excluding 
patients with neurological comorbidity. In cognitive outcome, a generalized effect 
on intelligence was observed on a group level in children with heart or kidney Tx, 
particularly in children with neurological or neuroradiological abnormality. Liver Tx 
children exhibited age-appropriate intelligence. In neuropsychological functions, all 
Tx groups exhibited specific visuomotor and visuoconstructive impairment. 
Neurological comorbidity, early onset of disease, longer disease duration before Tx, 
and – for kidney Tx children – poorer graft function at follow-up were important risk 
factors for cognitive outcome.  
In behavioral outcome, no significant differences were observed in HRQOL or 
PSA between heart, kidney, or liver Tx children. More Internalizing and Total 
Problems emerged in parent and teacher-ratings, but not in self-reports. In self-
reported HRQOL, however, lower ratings were observed in specific health 
dimensions. Longer follow-up time since Tx was associated with better behavioral 
outcome, and adolescents showed better HRQOL than did preadolescents. 
Neurological comorbidity was associated with both self-reported HRQOL and 
proxy-reported PSA, yet family structure and parental HRQOL also influenced the 
child’s PSA.  
 
5.1 Cognitive outcome 
5.1.1 Intelligence 
 
Reports indicate that children who have undergone organ Tx exhibit intelligence in 
the average to low-average range (LaRosa et al., 2011). The present study observed 
a generalized effect on intelligence of the suggested size after heart and kidney Tx 
with average group scores in the low-average or borderline range, while liver Tx 
children performed in the average range (see Table 4). 
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 Lower FSIQ, compared to test norms or a matched control group, is a common 
finding in studies assessing heart Tx children (Baum et al., 2004; Ikle et al., 2003; 
Mahle et al., 2006; Wray et al., 1994; Wray & Radley-Smith, 2005) as well as in 
children with non-transplant cardiac surgery (Hülser, Dubowy, Knobl, Meyer, & 
Schölmerich, 2007; Karsdorp, Everaerd, Kindt, & Mulder, 2007; Miatton, De Wolf, 
François, Thiery, & Vingerhoets, 2007; Sarajuuri et al., 2007). Other studies of 
pediatric heart Tx have reported FSIQs of 80-89 on the Wechsler Intelligence scales 
(Baum et al., 2004; Ikle et al., 2003; Krishnamurthy et al., 2011; Mahle et al., 2006), 
which are well in line with our results (average FSIQ of 86). Cognitive impairment 
has been observed in infant heart Tx recipients, with 34% exhibiting mental delay, 
41% language delay, 52% motor delay, and 48% delay in adaptive behavior defined 
as more than 2 SD below test norms (Joffe et al., 2011). In school-aged children, 
studies have reported below-average FSIQ in nearly one third of patients who 
underwent a heart Tx during their first year of life (Baum et al., 2004) and in almost 
half of the heart or lung Tx children transplanted at various ages (Brosig et al., 
2006). In contrast, however, 26% of the heart Tx children in our study had below-
average FSIQs. These results seem promising for school-aged children with heart 
Tx, especially in light of the more stringent exclusion criteria used in many previous 
studies. However, studies reporting the outcome of infant heart Tx recipients 
generally seem to suggest poorer cognitive outcome (Baum et al., 2004; Mahle et al., 
2006), likely due to the more severe course of the disease (Karsdorp et al., 2007). 
Similarly in our study, congenital disease, number of heart surgeries, and 
pathological brain findings pre-Tx explained some of the deterioration in cognitive 
outcome, indicating an effect of disease severity. 
 For kidney Tx recipients, the average FSIQ of 84 reported in our study was 
poorer than that in earlier studies (values range between 87 and 103; Falger et al., 
2008; Fennell et al., 1984; Lawry et al., 1994; Mendley & Zelko, 1999; Qvist et al., 
2002). This may have resulted from younger age at Tx in our study as well as the 
different inclusion criteria. Many earlier studies have excluded patients with, for 
example, cognitive delay (Fennell et al., 1990; Mendley & Zelko, 1999). As a result, 
a comparably high percentage of our patients fell in the cognitively delayed range 
(i.e., below average, 18%). When children with neurological comorbidity (including 
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those with a diagnosis of mental retardation) were excluded from the analyses of the 
current study, the average FSIQ of the Tx group fell in the normal-average range (an 
average FSIQ of 91). However, performance was still statistically significantly 
below test norms. Similarly, Qvist and colleagues (2002) at the Childrens’s Hospital 
in Helsinki found average intelligence in the patient group attending normal class 
(VIQ 92, PIQ 93), although when all kidney Tx children were included, both values 
were the lowest reported to date in the pediatric kidney Tx literature (VIQ and PIQ 
88). This study also included children transplanted at an early age (Qvist et al., 
2002). Another study that included all patients (Falger et al., 2008) used median 
values instead of mean values. When reported as median values, our kidney Tx 
sample had a mean FSIQ of 89, which is notably lower than that reported by Falger 
and colleagues (median FSIQ 97). Differences in study samples may have affected 
the results. Despite spending similar time on dialysis, our patients received 
transplants at a younger age and had poorer growth, which may indicate a more 
severe course of disease.  
Liver Tx patients reached a relatively good general cognitive level, as evidenced 
by their mean FSIQ of 94, compared to that in previous studies of school-aged 
children assessed with the Wechsler Intelligence scales (FSIQ of 86-95; Adebäck et 
al., 2003; Kennard et al., 1999; Krull et al., 2003; Sorensen et al., 2011). In the 
pediatric liver Tx literature in particular, studies have employed a variety of 
exclusion criteria. Even though we included all patients, only 11% of our liver Tx 
patients had below-average FSIQs, compared to 4% to 27% in other studies 
(Adebäck et al., 2003; Gilmour et al., 2009; Kennard et al., 1999; Sorensen et al., 
2011). Furthermore, studies report that 26% to 50% of liver Tx patients (compared 
to 11% in our sample) score in the borderline range, indicating a possible need for 
special education services (Adebäck et al., 2003; Sorensen et al., 2011). 
Additionally, all of our patients received an organ from a deceased donor, whereas 
many other studies report results from recipients of organs from both a deceased 
donor and a living relative. The latter has been associated with shorter disease 
duration, younger age at Tx, and possibly better cognitive outcome (Kaller et al., 
2005; Kaller, Langguth et al., 2010; Schulz et al., 2003). On measures of global 
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intelligence, only PIQ differed significantly from the population mean. Thus, the 
cognitive outcome for the majority of our liver Tx patients is reassuring. 
 Approximately one third of our Tx patients had a significantly lower PIQ 
compared to VIQ. Previous studies have reported a significantly lower PIQ 
compared to VIQ in kidney and liver Tx recipients (Adebäck et al., 2003; Falger et 
al., 2008). However, not all studies have confirmed this discrepancy (Fennell et al., 
1984). Overall, the results suggest that in a national sample of Finnish Tx patients, 
without excluding patients with neurological comorbidity, the majority had 
reassuring outcomes on measures of global intelligence. However, a significant 
minority exhibited a generalized effect on intelligence, mainly in association with 
neurological comorbidity. On the group level, heart and liver Tx children had 
similar, or slightly better, performance than that reported in previous research, yet 
kidney Tx children exhibited more global delay. The findings highlight the greater 
effect on PIQ, particularly on Block Design, compared to VIQ. 
  
5.1.2 Neuropsychological profile 
 
A pattern of effects was observed in the neuropsychological profiles of the Tx 
children. The greatest differences between the Tx groups and their matched control 
groups occurred on the paper-and-pencil tasks assessing visuomotor and 
visuoconstructive functions; scores for all Tx patients fell in the borderline range. 
On a non-motor visuospatial task, kidney and liver Tx children scored significantly 
lower than did their control groups, with a trend emerging in the heart Tx group. In 
addition, parental evaluations revealed an increased incidence of problems in motor 
skills and perception across groups. These visuomotor and visuoconstructive deficits 
were also observed in children without neurological comorbidity, who had a group 
mean of average intelligence. 
Studies of infant heart (Fleisher et al., 2002; Freier et al., 2004; Joffe et al., 2011; 
Wray & Radley-Smith, 2005), kidney (Davis, Chang, & Nevins, 1990), or liver Tx 
recipients (Gilmour et al., 2009) often report delayed psychomotor development. 
Evidence is also mounting that visuomotor and visuospatial impairment is present in 
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school-aged children after heart (Baum, Freier, Freeman, & Chinnock, 2000; Baum 
et al., 2004; Mahle et al., 2006; Uzark et al., 2009), kidney (Falger et al., 2008), and 
liver Tx (Stewart et al., 1991; Yssaad-Fesselier et al., 2009). Immunosuppressive 
medication, which may cause mild tremor even at normal blood levels (Gijtenbeek, 
van den Bent, & Vecht, 1999), may account for part of this impairment. However, 
studies on children with surgically corrected heart diseases and children on the 
waiting list for either heart/heart-lung Tx or kidney Tx also show delayed 
psychomotor development in infancy or fine motor and visuospatial difficulties at 
school-age (Bellinger et al., 2003; Davis et al., 1990; Wray & Radley-Smith, 2004). 
Nevertheless, some improvement may occur post-Tx. An early study reported the 
greatest pre- to post-kidney Tx improvement in PIQ (assessed by Picture 
Completion, Block Design, and Object Assembly) and mathematics compared to a 
healthy control group (Fennell et al., 1984). More specifically, Mendley and Zelko 
(1999) found pre- to post-kidney Tx improvement on computer-based testing in 
motor-free decision speed, but not in motor speed per se (Mendley & Zelko, 1999). 
Taken together, these findings imply a possibly irreversible effect of childhood end-
stage organ failure and consequent Tx on neuropsychological outcome, and that 
visuospatial, visuomotor, and fine motor functions are particularly sensitive. 
Visuospatial impairments may underlie math difficulties reported by parents of 
Tx children in this study (Swanson, 2012). The current Tx children showed a more 
than two-fold increase in the incidence of full-time special education and two- to 
three-fold increase in part-time special education services over that of the general 
population due to their learning disability in mathematics (Official Statistics of 
Finland., 2009). The numbers of children in special education and children with low 
IQ scores were similar, except for the kidney Tx group. The amount of special 
education was less than expected from the number of kidney Tx children with IQs in 
the borderline or below-average range. In addition, only one heart Tx patient and 
three kidney Tx patients had been diagnosed with mental retardation (data not 
presented), although five heart, nine kidney, and two liver Tx patients scored below 
average (FSIQ < 70). This is in accordance with the results of other studies on 
children with solid organ Tx, where cognitive impairment and the need for 
interventions at school have been under-recognized (Gilmour et al., 2009; Kennard 
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et al., 1999). Some researchers have suggested that teachers may have different 
expectations for the school achievements of sick children (Wray et al., 1994). 
However, underachievement and poorer school functioning have also been 
associated with absence from school among heart and liver Tx children (Alonso et 
al., 2010; Wray et al., 2001). Thus, hospital schools play an important role in helping 
children maintain their school work during hospital stays. 
In addition to shared difficulties in the neuropsychological domains of 
visuospatial, motor, and construction, other areas of neuropsychological functioning 
were also affected. Social perception has not earlier been assessed with standardized 
measures in this patient population. All Tx groups scored lower on a test of Affect 
Recognition than did their control groups. In children without neurological 
comorbidity, the significance remained only in the kidney and liver Tx groups. This 
test requires primarily the ability to read emotional expressions, but may also 
manifest as a secondary deficit following problems in visual discrimination, face 
recognition, working memory, or language (Korkman, Kirk, & Kemp, 2007b). The 
specific task of analyzing children’s facial expressions may thus be difficult because 
of an impairment in visual perception. A related function, Memory for Faces, was 
intact, however. Previous studies have reported average face recognition in liver Tx 
children (Krull et al., 2003). The simpler task of face discrimination and recognition 
appears to be age-appropriate, yet the more complex task of reading and interpreting 
facial expressions is impaired. Results of questionnaire studies on social functioning 
have been mixed. Social functioning has fallen within normal limits when rated by 
both liver Tx patients and their parents (Gilmour et al., 2009; Schulz et al., 2003), 
but sometimes problems have been reported in all Tx groups (Alonso et al., 2010; 
Qvist et al., 2004; Wray & Radley-Smith, 2007). In this study, parents reported 
problems in social functioning on two different questionnaires, indicating a possible 
effect of disease and treatment on social functions. Teachers, on the other hand, 
reported no social problems. 
Language and memory difficulties in our study were attributable mainly to a 
generalized cognitive impairment in the heart and kidney Tx children with 
neurological comorbidity. Hearing loss may have affected their language 
development and should be controlled for in this patient population (Bucuvalas et 
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al., 2003). In children without neurological comorbidity, impairment in receptive 
language occurred only in kidney Tx children. Numerous previous studies on 
pediatric organ Tx have reported language delays (Fleisher et al., 2002; Krull et al., 
2003), often occurring together with visuomotor and visuospatial impairment (Baum 
et al., 2004; Mahle et al., 2006). Yet, others have found impairment mainly in PIQ, 
visuospatial, and fine motor functions (Brouhard et al., 2000; Falger et al., 2008; 
Stewart et al., 1991; Yssaad-Fesselier et al., 2009). Thus, certain risk factors may 
affect language development rather than visuospatial functions. In older children, 
language skills may have already developed, and adverse events are more likely to 
affect new or developing skills. According to a recent study, executive functions, 
visuospatial performance, and verbal memory are indeed skills that mature later than 
social perception and language (Korkman, Lahti-Nuuttila, Laasonen, Kemp, & 
Holdnack, 2012). 
Despite their relatively good performance on the current tests of memory and 
learning, parents reported a significant increase in memory problems across Tx 
groups, and an increase in learning problems in kidney and liver Tx groups. Few 
other studies have included measures of memory functions. Reports indicate that 
liver Tx children score lower in memory and learning than do children with cystic 
fibrosis, though mean scores still fall in the average range (Krull et al., 2003; 
Stewart et al., 1991). Similarly, a large study of liver Tx children reported impaired 
working memory on computer-based testing when compared to the test norms, with 
mean scores in the low-average range (Kaller, Langguth et al., 2010). In kidney Tx 
children, performance on a working memory test requiring arithmetic skills 
improved from pre- to post-kidney Tx (Mendley & Zelko, 1999). Group-level 
memory and learning in the average range has been reported post-Tx, yet 20% 
performed at or below the borderline level (Qvist et al., 2002). Similarly, other 
studies have reported impairment in short-term memory after heart Tx (Wray et al., 
1994). A test of Word List Interference confirmed lower working- and short-term 
memory in the heart and kidney Tx children in our study, yet the significance did not 
remain in children without neurological comorbidity. 
In the Executive Functions domain, only Auditory Attention was assessed; of all 
the subtests in this domain, it has been shown to be the most sensitive to attention 
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deficit/hyperactivity disorder (Korkman, Kirk, & Kemp, 2007b). No difficulties 
were observed in the simple Auditory Attention task. The more complex task of the 
Auditory Attention and Response Set, where the child must shift and inhibit 
responses, was poorer in kidney Tx children than in their control group. Similarly, a 
significant increase in parent-reported problems in Executive Functions (including 
attention) in the Five to Fifteen occurred only in the kidney Tx recipients. Again, 
these attention problems were attributable mainly to the generalized effect observed 
in kidney Tx recipients with neurological comorbidity. Similarly, when assessing Tx 
children as one group, the ASEBA questionnaires revealed no self-, parent-, or 
teacher-reported attention problems. Questionnaire studies have reported conflicting 
results not only between studies, but also between raters, with teachers of liver Tx 
children reporting more executive problems and attention deficits than the children’s 
parents reported (Sorensen et al., 2011). Standardized measures of attention have 
rarely been used in this patient population, though studies have attributed reduced 
attention to kidney failure (Gerson et al., 2006; Gipson, Duquette, Icard, & Hooper, 
2007), and identified an improvement in sustained visual attention and stimulus 
discrimination sensitivity on a computerized continuous performance test from pre- 
to post-Tx (Mendley & Zelko, 1999). One study of kidney Tx children used a similar 
auditory attention task as the simple auditory attention task used in our study, and 
found no impairment (Fennell et al., 1984). Similarly, a previous study of kidney Tx 
children from the Childrens’s Hospital in Helsinki found no group-level impairment 
in attention assessed by the NEPSY; however, 24% of kidney Tx children performed 
at borderline level or below average (Qvist et al., 2002). A recent study of liver Tx 
children found low average scores on a complex computerized attention test, with 
sustained attention particularly affected (Kaller, Langguth et al., 2010). 
Consequently, a computerized attention test, or a more complex task that includes 
both shifting and inhibition, may be more sensitive in detecting even subtle changes. 
Based on the visuospatial impairments observed, more problems may emerge in a 
visual (vs. auditory) attention measure. Clinical assessment of Tx children should 
also take into account the impact of emotional adjustment difficulties on attention 
and memory functions.  
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Although differences were observed between subtest scores, the overall shapes of 
the test profiles of heart and liver Tx children did not differ significantly from their 
control groups. More research assessing several neuropsychological domains in the 
same patients as well as associated risk factors are needed to further interpret these 
findings. Overall, the neuropsychological test profile of Tx children is in line with 
the observed effect on PIQ. The findings highlight the impact on visuospatial, 
visuomotor, and visuoconstructive functions. In the future, assessment of tremor is 
important in order to analyze its effect on the visuomotor difficulties. Only children 
with neurological comorbidity exhibited impairments in attention, language, and 
memory due to a more generalized effect on neuropsychological outcome in this 
group, except for receptive language impairment in kidney Tx children without 
neurological comorbidity.  
The neuropsychological profile of Tx children, particularly after liver Tx, 
resembles that of nonverbal learning disorder described extensively by Rourke since 
the 1980s (Rourke, 1995), and which is still employed today (Forrest, 2004); 
research on the exact definition is ongoing. An early study by Stewart and 
colleagues suggested similar right-hemisphere dysfunction in pediatric liver Tx 
recipients (Stewart, Campbell, McCallon, Waller, & Andrews, 1992). Areas that 
have often been impaired in nonverbal learning disorder include visuospatial 
processing, motor coordination, social perception (emotional and nonverbal cues), 
mathematics, and the solving of novel and complex tasks (Semrud-Clikeman, 
Walkowiak, Wilkinson, & Christopher, 2010; Semrud-Clikeman, Walkowiak, 
Wilkinson, & Minne, 2010). The visuospatial problems are generally observed as a 
significantly poorer PIQ compared to VIQ as well as difficulties in copying complex 
figures (Semrud-Clikeman, Walkowiak, Wilkinson, & Christopher, 2010). However, 
the most essential defining features are still under debate and symptoms overlap 
considerably with other diagnoses, such as Asperger’s syndrome. Hence, nonverbal 
learning disorder is not yet accepted in the Diagnostic and Statistical Manual of 
Mental Disorders and is, therefore, not a formal diagnosis. 
Hypotheses attribute the cause of the symptoms associated with the nonverbal 
learning disorder to dysfunction in or damage to the white matter in the right 
hemisphere of the brain, which leads to dysfunction in intermodal integration 
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(Rourke, 1995). Evidence from an EEG study supports this hypothesis with long-
distance gamma-band hypoconnectivity in the right hemisphere of children with the 
disorder (Njiokiktjien, de Rijke, & Jonkman, 2001). Further, a magnetic resonance 
imaging study has recently revealed benign brain abnormalities in the occipital or 
parietal regions in 25% of affected children (Semrud-Clikeman & Fine, 2011). 
However, because white matter anomalies regularly appear in various other 
childhood disorders, a critical review of literature on nonverbal learning disorder 
calls for more specific information on the type of white matter deficit to explain the 
symptoms (Spreen, 2011).  
 
5.1.3 Organ-specific diagnostic subgroups 
 
Differences in cognitive outcome between organ-specific diagnostic groups were 
difficult to establish. This is in accordance with previous studies. The lack of 
significant associations has resulted from small sample sizes limiting statistical 
power. However, it is quite well established that, because of its more complicated 
disease course, a diagnosis of CHD is associated with a more probable 
developmental delay both pre- and post-Tx than is a diagnosis of cardiomyopathy 
(Joffe et al., 2011; Wray & Radley-Smith, 2004). In a meta-analysis of children with 
non-transplant CHD, cognitive deficits were associated with disease severity, 
impacting PIQ in particular (Karsdorp et al., 2007). A diagnosis of CHD is 
associated with risk factors such as frequent heart surgeries, poor cerebral perfusion, 
and neuroradiological abnormalities (Licht et al., 2004). Similarly, in our sample, 
children with CHD had undergone corrective heart surgery pre-Tx, while none of the 
children with cardiomyopathy had undergone corrective heart surgery. 
Consequently, patients with CHD had a significantly longer disease duration pre-Tx 
than did patients with cardiomyopathy, yet their length of time on the waiting list 
were similar. Children with CHD presented with brain abnormality more often than 
did children with cardiomyopathy. Compared to children with CHD, children with 
cardiomyopathy may experience normal, or near normal, development with acute 
disease onset (Mohammad & Alonso, 2010). 
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  Concern has grown about an adverse neurodevelopmental outcome in children 
with an initial diagnosis of CNF (Qvist et al., 2002; Valanne et al., 2004). These 
patients, with a lower gestational age and birth weight, are severely ill from birth 
(Huttunen, 1976; Patrakka et al., 2000) and undergo Tx at a significantly younger 
age than do children with other diagnoses. Yet, their cognitive outcome was 
surprisingly good; they had similar outcome as did children with other diagnoses. 
Interestingly, a trend for better functions in the visuospatial domain was observed. 
When children with CNF were compared to children with other congenital kidney 
diseases, this difference became significant. CNF children experienced significantly 
shorter disease duration than did children with other diagnoses, a result associated 
with better cognitive outcome. We are unaware of other studies reporting the 
cognitive outcome of CNF children only. Qvist and colleagues reported a high 
percentage of border zone infarcts on magnetic resonance imaging among the first 
kidney Tx patients at the Childrens’s Hospital in Helsinki, the majority of whom had 
CNF (Qvist et al., 2002; Valanne et al., 2004). Similar to our results on patients with 
CNF, these first patients had no PIQ-VIQ split. These patients received kidney Tx 
between 1987 and 1995, while anti-coagulation treatment was introduced in 1989 as 
a routine treatment for patients with CNF. The majority of patients with border zone 
infarcts received no anti-coagulation treatment and suffered seizures and 
hypertensive crises prior to Tx (Qvist et al., 2002). Their long-term behavioral and 
educational outcome, however, have been comparable to those of patients without 
border zone infarcts (Haavisto, Jalanko, Sintonen, Holmberg, & Qvist, 2011), yet 
their long-term cognitive outcome has not been studied. Hypertension, seizures, and 
pulmonary edema among patients on peritoneal dialysis have since decreased 
(Holtta, Rönnholm, Jalanko, & Holmberg, 2000). Improved treatment and early Tx 
in this large diagnostic group seems to result in improved cognitive outcome. 
In liver Tx patients, no differences emerged between those with biliary atresia, a 
congenital disease, and other diagnoses (both congenital and acquired). The first 
studies of pediatric liver Tx associated poorer cognitive outcome with early onset of 
liver disease and a diagnosis of biliary atresia (Stewart et al., 1989; Stewart et al., 
1992). Studies of more recent patient cohorts have reported contradictory results 
regarding the influence of age at disease onset or at Tx (Kaller et al., 2005; Kaller et 
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al., 2010; Kennard et al., 1999; Schulz et al., 2003; Wayman et al., 1997). In a recent 
study, patients with biliary atresia had a better cognitive outcome than did those with 
other infantile onset liver diseases requiring liver Tx (Gilmour et al., 2009).  
Overall, different diagnostic subtypes exhibit different disease courses and 
pathophysiology, which may affect cognition differently (Stewart et al., 1994). In 
heart Tx, children with CHD are generally at greater risk for cognitive impairments 
than are children with cardiomyopathy. In kidney Tx, children with CNF had similar 
outcomes as children with other diagnoses, except for less visuospatial impairment. 
In liver Tx, no effect of diagnosis (biliary atresia vs. other) emerged.  
  
5.1.4 Risk factors for cognitive outcome 
 
In heart and kidney Tx children, the greatest neuropsychological impairments – 
acquired mainly pre-Tx – occurred in patients with neurological or neuroradiological 
abnormality. These high-risk groups scored at or nearly 2 SD below average on the 
FSIQ, indicating significant cognitive delay, and had generalized difficulties across 
their neuropsychological test profile. 
Congenital (vs. acquired) disease in heart and liver Tx patients, and longer 
disease duration in liver Tx patients were associated with lower visuospatial 
functions. Congenital disease was also associated with longer disease duration 
before heart and liver Tx. The opposite was true for kidney Tx, because children 
with CNF received Tx earlier in life than those with other congenital diseases. Thus, 
early, prolonged insufficiency of blood oxygenation in heart disease and the 
circulation of toxic substances before kidney and liver Tx seemed to lead to lower 
visuospatial processing, regardless of time on dialysis or bilirubin levels. The 
smaller effect on visuospatial processing in CNF supports these findings, since CNF 
in newborns specifically leads to loss of protein in urine and abnormally low levels 
of protein in the blood, with uremia being less common prior to nephrectomy 
(Jalanko, 2009). In heart Tx children, corrective heart surgeries, undertaken in 
patients with CHD were associated with lower Executive Functions, assessed by the 
subtest of Auditory Attention and Response Set. Similarly, a Finnish sample of 
children with univentricular hearts who had undergone one or more non-transplant 
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corrective heart surgeries scored in the borderline range in the Auditory Attention 
subtest of the NEPSY (Sarajuuri et al., 2007). 
Longer follow-up time was in heart and kidney Tx patients associated with poorer 
scores in certain subtests. In the liver Tx group, however, longer follow-up time was 
associated with better scores. Follow-up times did not differ between groups. 
However, liver Tx children had a significantly shorter disease duration and waiting 
time for Tx than did children with a heart or kidney Tx. Longer disease duration 
could lead to poorer long-term rehabilitation even after Tx. However, liver Tx 
children also had better cognitive outcome in general. With their better cognitive 
capacity they may have been able to acquire new skills more efficiently in the post-
Tx period compared to heart and kidney Tx children. A decrease in hand-eye 
coordination and arithmetic in short-term follow-up of heart Tx children have been 
reported previously (Freier et al., 2004; Wray & Radley-Smith, 2005; Wray & 
Radley-Smith, 2006). More studies on the longitudinal effect of heart disease and 
consequent Tx on visuospatial skills are needed. In kidney Tx children, weakened 
graft function may further have played a role in their long-term outcome. However, 
more research is needed in order to resolve this issue. 
In kidney Tx patients, poorer graft function at the time of assessment associated 
with poorer language and memory skills as well as auditory attention. Kidney 
function has been associated with intellectual and academic outcomes in children 
with chronic kidney disease (Duquette, Hooper, Wetherington, Icard, & Gipson, 
2007), and with memory functions in kidney Tx children (Fennell et al., 1990). In 
other studies, kidney function failed to correlate with cognitive outcome (Davis et 
al., 1990; Falger et al., 2008). Our patients had a poorer glomerular filtration rate 
than did patients in several previous studies (Mendley & Zelko, 1999). However, we 
used a measured glomerular filtration rate (51Cr-ethylenediamine tetraacetic acid 
clearance), which yields stricter values than does an estimated glomerular filtration 
rate calculated, for example, with the Schwartz formula (Schwartz, Haycock, 
Edelmann Jr., & Spitzer, 1976). In addition, kidney function tends to deteriorate 
over time (Ortiz et al., 2005; Qvist et al., 1998; Qvist et al., 1999). While other 
studies have assessed patients approximately one (Davis et al., 1990; Fennell et al., 
1984; Mendley & Zelko, 1999) or six years post-kidney Tx (Falger et al., 2008; 
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Qvist et al., 2002), our patients were assessed on average seven years (range 1-14 
years) post-kidney Tx. In all heart and liver Tx children, graft function was normal 
at the time of assessment and, thus, its association to outcome was not analyzed. In 
the liver Tx group, the highest bilirubin level before Tx showed no association with 
later cognitive outcome. Earlier, Wayman and colleagues reported no association 
between parameters of disease severity (i.e., bilirubin and ammonia) and 
developmental outcome; parameters of malnutrition (i.e., albumin levels and poor 
growth before Tx), however, did show such an association (Wayman et al., 1997). In 
a more recent study, ammonia levels, associated with hepatic encephalopathy, and 
poor growth prior to liver Tx were specifically associated with lower PIQ and 
visuomotor integration (Gilmour et al., 2009). In our study, liver Tx children had the 
shortest disease duration, but showed the strongest correlations between disease 
duration and cognitive outcome, namely PIQ. Adding risk factors targeting 
malnutrition or using a cumulative value for pre-Tx blood values could have proved 
a more sensitive measure than a single measurement, even when using the highest 
value.  
Bypass time during heart Tx surgery showed no association with 
neuropsychological outcome in our study. Studies have shown that, in children who 
underwent heart surgery, cardiopulmonary bypass and circulatory arrest carry 
neurodevelopmental risks, specifically in visuospatial and visuomotor skills 
(Bellinger et al., 1999; Bellinger et al., 2003). However, other studies of heart Tx 
children have found no association between cognitive outcome and bypass time 
during Tx (Wray & Radley-Smith, 2006). Lastly, outcome showed no association 
with parental education, gender, or prematurity.  
Overall, numerous risk factors appear to affect developmental outcome. The 
greatest effect on cognitive outcome occurred in children with neurological 
comorbidity. Early onset and longer disease duration prior to Tx were associated 
with poorer cognitive functions, particularly visuospatial processing. In kidney Tx 
children, also graft function affected language skills, auditory processing, and 
memory.  
Although no comparison between Tx groups was undertaken, liver Tx patients 
consistently performed the best across cognitive outcome variables, and kidney Tx 
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patients, the poorest. This cannot be explained by numbers of children with 
neurological comorbidity, which were the lowest among kidney Tx children. 
However, kidney Tx children had a severe disease course. They were the youngest at 
disease onset and Tx, had the longest waiting time for Tx, and had the shortest 
stature both at Tx and at assessment. They were also the only Tx group who had 
weakened graft function. 
 
5.1.5 Mechanisms  
  
The six heart Tx patients in this study who had undergone pre-Tx brain imaging had 
various findings. Earlier, more systematic studies have found a high incidence of 
periventricular leukomalacia both in newborns with CHD and in neonates 
undergoing heart surgery (Licht et al., 2004; Mahle et al., 2002). Besides younger 
age at surgery, identifiable risk factors for periventricular leukomalacia include a 
longer time on cardiopulmonary bypass, hypoxemia, and hypotension (Galli et al., 
2004). Periventricular brain damage, associated with fine motor deficits in 
particular, but also with visuospatial difficulties in preterm infants (Jakobson, Frisk, 
Knight, Downie, & Whyte, 2001), may explain the deficits observed in the heart Tx 
population.  
In end-stage kidney or liver disease, encephalopathy may develop. Some 
evidence in the adult liver Tx literature seems to indicate an adverse effect of pre-Tx 
hepatic encephalopathy on post-Tx brain volumes and neuropsychological functions 
(Garcia-Martinez et al., 2011; Sotil, Gottstein, Ayala, Randolph, & Blei, 2009). In 
addition, malnutrition prior to liver Tx and, in end-stage kidney disease, prior to the 
initiation of dialysis is of concern (Laakkonen, 2011; van Mourik et al., 2000), since 
malnutrition in early life can affect brain development (e.g., myelination) and later 
cognitive functioning (Majovski & Breiger, 2009; Wayman et al., 1997).  
In all Tx groups, immunosuppressive medication causes hypertension (LaRosa et 
al., 2011). In kidney disease, however, hemodynamic changes already appear before 
Tx, particularly during dialysis. Hemodynamic crises have been associated with 
ischemic lesions in the zones between major arterial areas (i.e., the watershed areas), 
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as occurred in 54% of the first young patients treated with kidney Tx at the 
Childrens’s Hospital in Helsinki (Valanne et al., 2004). Mild ischemic changes in 
the watershed areas have also been reported in children with univentricular hearts 
without Tx (Sarajuuri et al., 2007). Post-Tx, similar lesions in the watershed areas 
are evident in posterior reversible encephalopathy syndrome. Since this syndrome 
was first described in 1996 (Hinchey et al., 1996), and because our study involved 
patients transplanted between 1993 and 2007, this fairly recent diagnosis may have 
been overlooked. It presents as altered consciousness, seizures, headache, and/or 
visual abnormalities, with acute hypertension and immunosuppressive medication as 
common triggers (Erol et al., 2007; Onder et al., 2007). Disturbed cerebral 
autoregulation causes vasogenic edema in the watershed area. The prevalence of 
posterior reversible encephalopathy syndrome in the pediatric Tx population may be 
higher than in adults, in whom prevalence has been 0.6% among liver Tx recipients 
(Bartynski, Tan, Boardman, Shapiro, & Marsh, 2008). Incidence rates have been 
10% in children with liver Tx (Erol et al., 2007) and 9% in children with kidney Tx 
or end-stage renal disease (Onder et al., 2007). Similar neurotoxicity has been 
reported in the use of OKT3 antibody in treating corticosteroid-resistant graft 
rejection (Parizel et al., 1997). In posterior reversible encephalopathy syndrome, the 
bilateral white matter signal abnormalities, seen mainly in the posterior cortical 
region, typically resolve within two weeks. However, subtle visuoperceptual 
abnormalities have been reported in short-term follow-up, after the cortical blindness 
resolves (Frutiger, Fennell, & Parsons, 1999). Its long-term neuropsychological 
effects are unknown.  
Also, numerous other factors may have played a role. Growth hormone resistance 
has been reported in children with chronic liver disease (Maes, Sokal, & Otte, 1997), 
with hormone levels turning to normal after Tx (Sarna, Sipilä, Vihervuori, 
Koistinen, & Holmberg, 1995). Growth hormone and growth hormone mediators are 
affected in several ways also in kidney failure (Mahan, Warady, & Consensus 
Committee, 2006). A recent study has shown an association between growth 
hormone deficiency and abnormalities in white matter fiber density, as well as 
impaired global cognitive functioning and motor skills in children with isolated 
growth hormone deficiency (Webb et al., 2012). Growth hormone treatment has 
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been associated with improvement in visuospatial functions across different 
pediatric groups, although the mechanisms by which this occurs remain unknown 
(Cody et al., 2005; Hokken-Koelega, van Pareren, & Arends, 2005; Huisman et al., 
2008).  
 To summarize, Tx children seem to be susceptible to negative effects in the 
posterior cortex and to exhibit associated visuospatial difficulties (Bear, Conners, & 
Paradiso, 2007). Hemodynamic changes have been reported in all Tx groups with 
diminished cerebral blood flow, hypoxemia, and hypotension in children with heart 
disease; hypertension and changes in blood pressure during dialysis; and post-Tx 
hypertension due to immunosuppressive medication. The watershed areas seem the 
most vulnerable to ischemic lesion resulting from altered cerebral blood flow 
(Bartynski et al., 2001).  
 
5.2 Behavioral outcome 
 
Although adult studies on long-term HRQOL have reported poorer outcome in 
kidney Tx recipients (Karam et al., 2003), our study supported the few studies 
conducted on pediatric patients that have reported similar HRQOL and post-
traumatic stress symptoms regardless of Tx type (Devine et al., 2010; Mintzer et al., 
2005). Similar to our study, previous comparison studies have had small sample 
sizes in at least one Tx group (Devine et al., 2010; Devine et al., 2011; Mintzer et 
al., 2005; Simons et al., 2008). Consequently, group sizes in pediatric studies may 
have been too small to detect statistically significant differences between Tx groups. 
Adjusting for disease duration and follow-up time in the present study may further 
have reduced power for detecting group differences by affecting variance. However, 
as this study presents one of the first comparison studies in the field, inclusion of 
covariates was considered the more conservative approach and was, therefore, 
chosen. Disease duration was used as a covariate because it varied significantly 
between the Tx groups and was associated with PSA. Follow-up time was used as a 
covariate because it correlated significantly with the outcome variable of HRQOL. 
However, results remained the same when disease duration and follow-up time were 
removed as covariates (data not presented). Other background variables analyzed in 
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Study IV that differed significantly between the groups (congenital disease, height at 
assessment, and immunosuppressive medication) correlated significantly with each 
other and the chosen covariates, and were, thus, not adjusted for. Their effect on 
outcome was evaluated in multiple regression analyses.  
In our study, kidney Tx children still had stable graft function. However, HRQOL 
in kidney Tx children may change due to the unavoidable deterioration in kidney 
function, which may ultimately lead to dialysis and re-Tx (LaRosa et al., 2011; 
Limbers et al., 2011). 
 
5.2.1 Health-related quality of life 
 
In this study, a preference-based health utility measure was used for HRQOL. It is 
not directly comparable with the Child Health Questionnaire, for example, or the 
Pediatric Quality of Life Inventory (PedsQL®) used in most previous studies. 
Studies assessing health utility have used instruments developed mainly for the adult 
population, yet the valuation of health states between adolescents and adults seems 
to differ (Ratcliffe et al., 2012). A few studies reporting health utility after pediatric 
Tx have found decrements, but the specific domains in which problems arise vary 
(Apajasalo et al., 1997; Qvist et al., 2004; Tong et al., 2011). In our study, both 
preadolescent and adolescent patients experienced that their health made it more 
difficult to be with friends, and to attend school or to participate in hobbies. Besides 
missing school for regular hospital visits at the local hospital, all Tx children and 
adolescents had to travel to Helsinki for annual health check-ups, causing them to 
miss several days of school. Both age groups also reported excretion problems, 
which have been associated as a side-effect of immunosuppressive medication 
(Schonder et al., 2010). Eating and mobility problems occurred in patients with 
neurological comorbidity (i.e., cerebral palsy due to asphyxia, severe neurological 
complications, sensory neuropathy). Similar to adolescent patients in our study, 
long-term adult survivors of pediatric liver Tx have reported better vitality than 
healthy controls (Mohammad et al., 2012).  
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A discrepancy emerged in self-reports between preadolescent and adolescent 
patients. A similar discrepancy emerged in the first pediatric patients transplanted at 
the Childrens’s Hospital in Helsinki and assessed with the same health utility 
measure. The authors hypothesized that this difference may have resulted from an 
altered perception of HRQOL after a life-threatening disease or denial due to fear of 
recurrence. However, in the first pediatric Tx sample, more preadolescent patients 
had more additional complications or diseases (Apajasalo et al., 1997). In our 
sample, the age groups did not differ with respect to neurological or psychiatric 
comorbidities. All patients received pre-Tx preparation and annual counseling as 
part of their treatment plan, and the medical treatment had changed little. However, 
preadolescents did have a shorter follow-up time, which was associated with lower 
HRQOL. Methodological issues may also have played a role, since the age groups 
completed different, albeit comparable, questionnaires. However, results remained 
also when comparing scores without their preference weight (data not presented), 
indicating more than a methodological bias. In younger children, studies have 
reported that parents did not provide their children with sufficient information (Gritti 
et al., 2001). It is therefore important to include patients, according to their 
developmental level, in their care, to describe procedures, and to discuss their 
thoughts about their state of health and its effect on their future. Health-care 
professionals are encouraged to help families maintain an open dialogue about their 
child’s disease and Tx to avoid it becoming a “family secret”.  
 
5.2.2 Psychosocial adjustment 
 
The increase in Internalizing Problems identified in parent reports was, as would be 
expected, attributable mainly to significant somatic complaints in 24% of the Tx 
patients. Items reflecting somatic complaints included nightmares, constipation, 
feelings of dizziness, excessive fatigue for no apparent reason, and physical 
problems with no known medical cause (e.g., aches or pains, nausea, and rashes). 
Similar side-effects have been reported in previous studies (Schonder et al., 2010; 
Taylor et al., 2009; Uutela et al., 2009). Although parental HRQOL did associate 
with parental evaluations of other PSA problems in their child, it did not associate 
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with evaluations of somatic complaints. The parents of Tx recipients have reported 
more problems in health and physical functions than have the patients themselves 
(Sundaram, Landgraf, Neighbors, Cohn, & Alonso, 2007), which is in accordance 
with our results. Adolescents may compare their health to their pre-Tx state, while 
parents may compare their child after Tx to the child’s same-aged healthy peers 
(Sundaram et al., 2007; Tong et al., 2011). Similarly, parents have more often 
reported PSA problems than have the adolescents themselves (Devine et al., 2010; 
Wu et al., 2008). In this study, it was impossible to determine whether adolescents 
had adjusted to their post-Tx condition or whether their strive for normalcy, as 
reported in other studies (Taylor, Franck, Dhawan, & Gibson, 2010; Wise, 2002), 
may have caused them to overlook their symptoms. It is also impossible to 
determine whether parents had a more accurate perception of their child in relation 
to age-expectations or whether they over-reported problems due to parental 
overprotectiveness of a chronically sick child. However, because of the generalized 
increase in PSA problems, behavioral, emotional, and social problems should be 
screened routinely in pediatric Tx recipients. Moreover, when the child experiences 
challenging events (e.g., medical complications, natural developmental stages, or 
adverse family events), psychosocial support should be readily offered. 
Teacher-reports have seldom been included. As did a previous study from the 
Childrens’s Hospital in Helsinki, we found that parents reported more problems than 
did teachers (Qvist et al., 2004), indicating that Tx children may be doing 
psychosocially relatively well in the classroom. Our good long-term outcome may 
also reflect the ambition at the Childrens’s Hospital in Helsinki to make a school 
visit when a Tx patient begins school, informing both classmates, teachers, and the 
school nurse about the Tx. Increasing awareness and openness is likely to improve 
adjustment to school and decrease the risk for bullying. Overall, proxies in our study 
reported more generalized PSA problems than did youth self-reports. Also, no 
association was found between teacher- and self-reports. Parents and teachers may 
be cautious about even small indications of emotional and behavioral problems in Tx 
children. Because of the discrepancies in reports, it is important in both research and 
clinical work to gather information from several sources. Some problems, 
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particularly neuropsychological ones, may be easier to identify in the school 
environment and others at home.  
 
5.2.3 Risk factors for behavioral outcome 
 
Of the disease-related variables, longer follow-up time was associated with better 
HRQOL and fewer somatic complaints, which may at least partially stem from a 
decrease in the side-effects of medication or in the effects of adverse medical events. 
While side-effects from medication decrease with time, the risk for developing a 
secondary chronic disease increases. Both factors have been found to negatively 
impact HRQOL (Simons et al., 2008; Taylor et al., 2009). However, these late 
effects may not have appeared in the follow-up times in this study. Longer follow-up 
time was also associated with less PSA problems, indicating better adjustment with 
time. This association was likely pronounced in our study, since follow-up times 
varied extensively from 1 to 15 years. Children with an acquired disease exhibited 
better HRQOL, but showed no difference in PSA. In earlier studies, acute disease 
and consequent Tx in adolescents associated with more post-traumatic stress 
symptoms than did chronic disease because of its sudden and life-changing course in 
previously healthy children (Mintzer et al., 2005).  
Longer disease duration was associated only with teacher-reported PSA 
problems. Also, longer disease duration in our patient sample was associated with 
poorer neuropsychological outcome. Thus, longer disease duration may impact 
learning and coping at school, even though the effects may not be evident in the 
home environment. Since teacher-reports have seldom been included, it is difficult 
to compare these findings to others. Other disease-related variables (i.e., age at Tx or 
at assessment, height at assessment, or type of immunosuppression) showed no 
association with outcome.  
Many family-related variables were associated with PSA. Lower parental 
HRQOL was associated with more parent-reported PSA problems in the child, while 
only the father’s HRQOL was associated with teacher-reported PSA problems. 
Earlier, parental physical functioning has been associated with self-reported physical 
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functioning among Tx adolescents (Simons et al., 2008). Including a variable on 
parental psychopathology has been suggested (Wu et al., 2008); it may be a more 
accurate measure than parental HRQOL. More studies that include parental 
wellbeing and teacher-ratings are needed to analyze the relevance of these findings. 
Another family-related variable that predicted PSA problems was a family 
structure where the child was not living with both biological parents, an association 
previously reported in a Finnish epidemiological study (Luoma et al., 1999). In our 
study, not living with both biological parents involved the alternatives of living with 
one parent or alternating between divorced parents, step-parenting, the death of one 
parent, foster care, and adoption. The number of Tx children living with both their 
biological parents was similar to that in the general population (73% vs. 75%; 
Statistics Finland, personal communication, 8 June 2012). Previous studies have 
found no association between marital status and behavioral outcome after Tx 
(Devine et al., 2010; Simons et al., 2008). Family structure may be a more sensitive 
measure. Previously, family conflict and impaired family functioning have been 
associated with poorer HRQOL in children and adolescents who have undergone 
organ Tx (Devine et al., 2011; Simons et al., 2008; Taylor et al., 2009). Even when 
family functioning was normal (Alonso et al., 2008), parents of pediatric Tx 
recipients commonly reported increased emotional stress, disruption of family 
activities (Alonso et al., 2008), and greater adjustments to family routines (Denny et 
al., 2012). These findings stress the importance of the holistic approach of treating 
young patients together with their families. The parents should regularly be asked 
about their own and the family’s wellbeing and receive counseling, if needed. In 
contrast to our expectations, parental educational level showed no association with 
outcome. However, parental education was classified as only two levels, which may 
have led to low sensitivity.  
Neurological comorbidity was an important risk factor for post-Tx PSA and 
HRQOL. Previous research has found an elevated risk for emotional and behavioral 
problems in chronically ill children, especially those with neurological disorders 
(Hysing, Elgen, Gillberg, & Lundervold, 2009). Similarly, more PSA problems 
emerged in kidney Tx recipients with neurological comorbidity (Qvist et al., 2004). 
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The classification of neurological comorbidity in the current study was broad, and 
the impact could vary greatly between patients.  
Psychiatric history has been associated with poorer psychological 
functioning in liver Tx children (Taylor et al., 2009). The number of children who 
had received psychological or psychiatric support after Tx was 22%, a percentage 
very similar to that in our study (26%). In most of our patients, a psychiatric 
diagnosis equalled mild to severe depression or post-traumatic stress disorder often 
related to the somatic disease, which would be expected to raise the Internalizing 
Problems score. However, the only outcome associated with psychiatric diagnosis 
was self-reported HRQOL.  
Overall, longer follow-up time and the absence of neurological comorbidity 
were important alleviating factors for behavioral outcome. The findings also 
highlight the impact of family structure and parental wellbeing; factors which have 
also been associated with PSA in healthy Finnish children (Almqvist et al., 1999; 
Sourander et al., 2006). Many of these risk factors have been associated with 
nonadherence to immunosuppressive medication, which is a recognized problem in 
adolescents with possible graft loss and death as outcome. The transition from 
pediatric to adult care is a particularly vulnerable period (Fredericks, Lopez, Magee, 
Shieck, & Opipari-Arrigan, 2007; LaRosa et al., 2011). 
 
5.3 Limitations of the study and suggestions for further 
studies 
 
This thesis presents a single-center study, and the results may differ between centers 
depending on, for example, health care (including psychosocial support, 
neuropsychological assessment, and rehabilitation services), Tx listing criteria, 
survival rates, and sample demographic characteristics. Small group sizes, differing 
diagnoses, and large intragroup age ranges may have made it more difficult to 
demonstrate statistically significant differences between groups.  
Studies I-III included all patients, even patients with re-Tx and combined liver-
kidney or heart-lung Tx. We approached these challenges by using 
neuropsychological tests designed for a wide age-range. All children could be 
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assessed with the same measures, yielding results that were generalizable across 
ages. Information also came from parents, thereby ensuring data from multiple 
sources. Further, the studies also included a healthy control group. 
WISC-III was published in 1999 and, consequently, has older norms than the 
NEPSY-II, published in 2008. It is also more reliable to compare results to a 
matched control group than to test norms. Thus, the results on the WISC-III may be 
taken as an orienting evaluation and the NEPSY-II results as the main results. On the 
Wechsler Intelligence scales, gains in scores generally emerge over time, particularly 
on the performance scale (Wechsler, 2003). Thus, the difficulties observed in the 
WISC-III in the Tx children might be even more pronounced when compared to the 
new normative data of the WISC-IV. 
Study IV was one of the first exploratory studies to compare behavioral outcome 
in three pediatric organ Tx groups. Future studies should replicate the findings with 
larger group sizes. Similarly, the number of children eligible to complete the youth 
self-report of PSA was limited and no Finnish norms for the ASEBA questionnaires 
were available. This posed no problem when comparing raw scores between Tx 
groups. However, the rates of children with clinically significant problems should 
not be taken as prevalence rates, since the rates reflect U.S. norms. The number and 
type of assessed risk factors were limited, and numerous other risk factors may have 
affected PSA and HRQOL (e.g., medication side-effects, secondary chronic disease, 
rejection episodes). Systematic collection of these data may prove helpful in 
assessing their importance (Taylor et al., 2009). Only ten kidney patients received a 
living-related donation, so its impact could not be analyzed.  
The generalizability of this study is quite good - the majority of eligible patients 
were recruited without exclusions. In the future, more multicenter studies and 
studies using a multi-informant approach are needed. No study thus far has 
compared neuropsychological outcome between heart, kidney, and liver Tx children. 
The latter has been proposed for determining similarities and differences in 
neuropsychological profiles (Fine et al., 2004). Assessment of adaptive behavior 
should be included in addition to cognitive tests to further analyze everyday 
functioning particularly in children with IQ scores below average. Measures of 
adaptive functions have, however, not yet been standardized in Finland. More 
88 
 
knowledge is also needed on brain mechanisms underlying cognitive effects. In 
behavioral outcome, qualitative interviews and studies on parent-child attachment 
would shed light on the emotional development of Tx children. Also, intervention 
studies for behavioral outcome are needed.  
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6 CONCLUSIONS AND CLINICAL IMPLICATIONS 
 
The first conclusion of this study is that a generalized effect on global intelligence 
can be observed in children who have undergone a heart or kidney Tx, particularly 
in children with neurological or neuroradiological abnormalities. Nevertheless, the 
presence of mental retardation and, in kidney Tx children, the need for special 
education services tend to be under-recognized.  
Second, in neuropsychological functions, a notable minority of patients had 
difficulties in visuomotor and visuoconstructive functions as well as in social 
perception, suggesting the need for further attention to nonverbal learning disorder 
in this patient group. Our results suggest that few problems emerge in attention, 
memory, and language. Evidently, assessment of global intelligence is insufficient, 
but needs to be complemented with a comprehensive neuropsychological evaluation. 
This patient group will require more special education services and remedial 
resources than unaffected children require, with special attention to their visuospatial 
processing and possible secondary problems in mathematics. They may also need 
support for their social perception and social skills. Since work requiring heavy 
physical effort may not be an option for all Tx children, optimizing learning is of 
great importance, as it improves future schooling and job opportunities. Of the risk 
factors, early Tx with shorter disease duration alleviated later cognitive outcome, 
particularly visuospatial functions, while neurological comorbidity strongly 
associated with global cognitive impairment. Further, poorer graft function at the 
time of assessment associated with lower verbal/auditory functions and memory in 
kidney Tx children.  
Third, organ type does not appear to have a major impact on HRQOL or PSA 
after pediatric Tx. Rather, Tx recipients share common threats to their well-being. 
Improved treatment in order to avoid comorbidity (e.g., neurological sequelae), will 
improve outcome, but may be counteracted in the future by extended inclusion 
criteria for Tx. Longer follow-up time after Tx was associated with improved 
HRQOL and PSA, but family-related variables are also important for the child’s 
adjustment. Consequently, families should routinely receive psychosocial support to 
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alleviate parental stress and family dysfunction for the benefit of the child. For the 
Tx child, new issues may arise during different developmental stages, and 
counseling as a routine part of treatment throughout childhood and adolesence is 
essential. 
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Appendix 1. Additional clinical data for the 87 transplant patients who participated in 
the study 
 Mean ± SD     Range 
Heart (n = 19)   
By pass time during heart Tx, min 175.2 ± 70.3  93.0-341.0 
Previous corrective heart surgeries (yes/no), n (%)         7 (37%) 2.0-6.0 
Left ventricular ejection fraction, %a 65.5 ± 6.1 54.0-77.0 
Fractional shortening, %b 35.4 ± 5.3 28.0-46.0 
Normal echocardiogram, n (%)       19 (100%)  
Kidney (n = 50)   
Time on dialysis pre-Tx, years 1.4 ± 1.2  0.01-5.8 
Glomerular filtration rate, ml/min/1.73 m2 c 47.5 ± 14.8 14.0-88.0 
Serum creatinine, mol/Ld 98.7 ± 62.3 38.0-452.0 
Liver (n = 18)   
Highest bilirubin level pre-Tx, mol/Le 524.9 ± 409.7 11.0-1279.0 
Galactose elimination capacity, minf   10.5 ± 1.3 8.0-13.0 
Tx, transplantation. 
Note. Data presented as mean ± 1 standard deviation and range, unless otherwise specified. 
Four children with a combined liver-kidney Tx are included in both the kidney and liver 
groups. Organ function was evaluated at the time of assessment. 
aNormal value: 55-75%. 
bNormal value: 28-38%. 
cGlomerular filtration rate was measured by 51Cr-ethylenediamine tetraacetic acid clearance 
(ml/min/1.73 m2). Normal values > 90 mL/min per 1.73 m2, near normal > 60 mL/min per 
1.73 m2. 
dNormal values for children aged 6–12 years, 10–76 mol/L; girls aged 13–16 years, 15–90 
mol/L; and boys aged 13–16 years, 20–95 mol/L. 
eThe highest serum or plasma bilirubin level before Tx was selected as an indicator of 
disease severity. Since bilirubin as a disease severity marker is irrelevant in ornithine 
carbamoyltransferase (OCT)-deficiency and hyperoxaluria, bilirubin values for patients with 
these diagnoses were not recorded. This information was missing for one child who 
underwent Tx abroad. Normal values: 4–20 mol/L. 
fGalactose elimination capacity was expressed as the half-life of its clearance (min). Normal 
elimination time < 15 min. 
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